John Ioannidis | Academic Influence

Q: What Schools Are Affiliated With John Ioannidis

John Ioannidis is affiliated with the following schools: Tufts University, University of Ioannina, Stanford University, National and Kapodistrian University of Athens, Harvard University

Why Is John Ioannidis Influential?

(Suggest an Edit or Addition)

According to Wikipedia, John P. A. Ioannidis is a Greek-American physician-scientist, writer and Stanford University professor who has made contributions to evidence-based medicine, epidemiology, and clinical research. Ioannidis studies scientific research itself, meta-research primarily in clinical medicine and the social sciences.

(See a Problem?)

John Ioannidis's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration (2009) (20340)
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration (2009) (13688)
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. (2009) (7631)
Why Most Published Research Findings Are False (2005) (7320)
Power failure: why small sample size undermines the reliability of neuroscience (2013) (5500)
Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials (2011) (4355)
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations (2015) (3720)
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. (2009) (3700)
Genome-wide association studies for complex traits: consensus, uncertainty and challenges (2008) (2939)
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration (2015) (2626)
Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial. (2011) (2348)
A manifesto for reproducible science (2017) (1958)
Replication validity of genetic association studies (2001) (1919)
Redefine statistical significance (2017) (1806)
Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis (2018) (1627)
Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson’s disease (2014) (1591)
Contradicted and initially stronger effects in highly cited clinical research. (2005) (1393)
Systematic Review of the Empirical Evidence of Study Publication Bias and Outcome Reporting Bias (2008) (1390)
The case of the misleading funnel plot (2006) (1340)
Why Most Discovered True Associations Are Inflated (2008) (1159)
Why Most Published Research Findings Are False (2005) (1149)
Increasing value and reducing waste in research design, conduct, and analysis (2014) (1144)
Better Reporting of Harms in Randomized Trials: An Extension of the CONSORT Statement (2004) (1135)
Genome-wide meta-analyses identify multiple loci associated with smoking behavior (2010) (1107)
How to increase value and reduce waste when research priorities are set (2014) (1064)
Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database (2008) (1064)
Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture (2012) (1045)
Uncertainty in heterogeneity estimates in meta-analyses (2007) (984)
Evaluation of networks of randomized trials (2008) (945)
The Hartung-Knapp-Sidik-Jonkman method for random effects meta-analysis is straightforward and considerably outperforms the standard DerSimonian-Laird method (2014) (937)
Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis (2012) (885)
Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis. (2005) (874)
Influence of Reported Study Design Characteristics on Intervention Effect Estimates From Randomized, Controlled Trials (2012) (871)
The appropriateness of asymmetry tests for publication bias in meta-analyses: a large survey (2007) (863)
The Mass Production of Redundant, Misleading, and Conflicted Systematic Reviews and Meta-analyses. (2016) (848)
Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials (2014) (831)
What does research reproducibility mean? (2016) (829)
Comparison of evidence of treatment effects in randomized and nonrandomized studies. (2001) (815)
Plea for routinely presenting prediction intervals in meta-analysis (2016) (767)
Reproducibility in Science: Improving the Standard for Basic and Preclinical Research (2015) (757)
Seven New Loci Associated with Age-Related Macular Degeneration (2013) (741)
Heterogeneity testing in meta‐analysis of genome searches (2005) (724)
Sensitivity of between-study heterogeneity in meta-analysis: proposed metrics and empirical evaluation. (2008) (713)
EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (2007) (698)
Twenty bone mineral density loci identified by large-scale meta-analysis of genome-wide association studies (2009) (687)
Summing up evidence: one answer is not always enough (1998) (672)
Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses? (2009) (658)
How to Make More Published Research True (2014) (619)
Genetic associations in large versus small studies: an empirical assessment (2003) (611)
Effect of the statistical significance of results on the time to completion and publication of randomized efficacy trials. (1998) (600)
EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases (2010) (599)
EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs (2010) (595)
Demystifying trial networks and network meta-analysis (2013) (581)
Assessment of cumulative evidence on genetic associations: interim guidelines. (2008) (559)
Meta-analysis in genome-wide association studies. (2009) (559)
Comprehensive Research Synopsis and Systematic Meta-Analyses in Parkinson's Disease Genetics: The PDGene Database (2012) (546)
Opportunities and challenges in developing risk prediction models with electronic health records data: a systematic review (2017) (545)
Repeatability of published microarray gene expression analyses (2009) (543)
A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy (2000) (543)
Evidence-based de-implementation for contradicted, unproven, and aspiring healthcare practices (2014) (532)
An exploratory test for an excess of significant findings (2007) (529)
Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies (2015) (528)
COVID-19 Antibody Seroprevalence in Santa Clara County, California (2020) (515)
Meta-analysis methods for genome-wide association studies and beyond (2013) (506)
Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease. (2006) (505)
Strengthening the reporting of genetic association studies (STREGA): an extension of the STROBE statement (2009) (494)
The Proposal to Lower P Value Thresholds to .005. (2018) (491)
Differential Effects of NOD2 Variants on Crohn's Disease Risk and Phenotype in Diverse Populations: A Metaanalysis (2004) (488)
STrengthening the REporting of Genetic Association Studies (STREGA)— An Extension of the STROBE Statement (2009) (482)
Clinical evolution, and morbidity and mortality of primary Sjögren's syndrome. (2000) (473)
Environmental risk factors and multiple sclerosis: an umbrella review of systematic reviews and meta-analyses (2015) (472)
HEGESMA: genome search meta-analysis and heterogeneity testing (2005) (472)
Relative citation impact of various study designs in the health sciences. (2005) (472)
Correlation of quality measures with estimates of treatment effect in meta-analyses of randomized controlled trials. (2002) (469)
'Racial' differences in genetic effects for complex diseases (2004) (461)
Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjögren's syndrome. (2002) (453)
Biomedical research: increasing value, reducing waste (2014) (448)
Percutaneous Coronary Intervention Versus Conservative Therapy in Nonacute Coronary Artery Disease: A Meta-Analysis (2005) (446)
Artificial intelligence versus clinicians: systematic review of design, reporting standards, and claims of deep learning studies (2020) (444)
Effect of Low-Fat vs Low-Carbohydrate Diet on 12-Month Weight Loss in Overweight Adults and the Association With Genotype Pattern or Insulin Secretion: The DIETFITS Randomized Clinical Trial (2018) (442)
Why Current Publication Practices May Distort Science (2008) (442)
Empirical assessment of published effect sizes and power in the recent cognitive neuroscience and psychology literature (2017) (441)
Mortality in systemic sclerosis: an international meta-analysis of individual patient data. (2005) (435)
Why Science Is Not Necessarily Self-Correcting (2012) (433)
Nationwide Population Science: Lessons From the Taiwan National Health Insurance Research Database. (2015) (431)
Comparative effectiveness of exercise and drug interventions on mortality outcomes: metaepidemiological study (2013) (426)
Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal (2010) (417)
Single or multiple daily doses of aminoglycosides: a meta- analysis (1996) (415)
Interpretation of tests of heterogeneity and bias in meta-analysis. (2008) (415)
Why Most Clinical Research Is Not Useful (2016) (413)
Integration of evidence from multiple meta-analyses: a primer on umbrella reviews, treatment networks and multiple treatments meta-analyses (2009) (410)
Treating anemia early in renal failure patients slows the decline of renal function: a randomized controlled trial. (2004) (403)
The Power of Bias in Economics Research (2017) (401)
Validating, augmenting and refining genome-wide association signals (2009) (394)
Publication and other reporting biases in cognitive sciences: detection, prevalence, and prevention (2014) (392)
Perinatal transmission of human immunodeficiency virus type 1 by pregnant women with RNA virus loads <1000 copies/ml. (2001) (389)
Identification of new susceptibility loci for osteoarthritis (arcOGEN): a genome-wide association study (2012) (382)
Reasons or excuses for avoiding meta-analysis in forest plots (2008) (380)
Effectiveness of antipsychotic treatments in a nationwide cohort of patients in community care after first hospitalisation due to schizophrenia and schizoaffective disorder: observational follow-up study (2006) (370)
Clinical interpretation and implications of whole-genome sequencing. (2014) (365)
Meta-Analysis: Test Performance of Ultrasonography for Giant-Cell Arteritis (2005) (353)
How to read a systematic review and meta-analysis and apply the results to patient care: users' guides to the medical literature. (2014) (352)
What causes psychosis? An umbrella review of risk and protective factors (2018) (352)
Hardy–Weinberg equilibrium in genetic association studies: an empirical evaluation of reporting, deviations, and power (2005) (350)
Predictive ability of DNA microarrays for cancer outcomes and correlates: an empirical assessment (2003) (348)
Standard 6: Age Groups for Pediatric Trials (2012) (347)
How to use a subgroup analysis: users' guide to the medical literature. (2014) (347)
How to use an article reporting a multiple treatment comparison meta-analysis. (2012) (345)
Early extreme contradictory estimates may appear in published research: the Proteus phenomenon in molecular genetics research and randomized trials. (2005) (332)
The infection fatality rate of COVID-19 inferred from seroprevalence data (2020) (332)
Heterogeneity in Meta-Analyses of Genome-Wide Association Investigations (2007) (328)
Autonomic denervation added to pulmonary vein isolation for paroxysmal atrial fibrillation: a randomized clinical trial. (2013) (325)
Differential genetic effects of ESR1 gene polymorphisms on osteoporosis outcomes. (2004) (324)
PRISMA harms checklist: improving harms reporting in systematic reviews (2016) (323)
Maintenance antiretroviral therapies in HIV-infected subjects with undetectable plasma HIV RNA after triple-drug therapy. AIDS Clinical Trials Group Study 343 Team. (1998) (316)
18F-fluorodeoxyglucose positron emission tomography to evaluate cervical node metastases in patients with head and neck squamous cell carcinoma: a meta-analysis. (2008) (315)
Public Availability of Published Research Data in High-Impact Journals (2011) (311)
Genetic associations: false or true? (2003) (301)
Translation of highly promising basic science research into clinical applications. (2003) (300)
Coronavirus disease 2019: The harms of exaggerated information and non‐evidence‐based measures (2020) (299)
Evolution of Reporting P Values in the Biomedical Literature, 1990-2015. (2016) (299)
Recommendations for Biomarker Identification and Qualification in Clinical Proteomics (2010) (298)
Big data meets public health (2014) (293)
Microarrays and molecular research: noise discovery? (2005) (284)
Impact of violations and deviations in Hardy-Weinberg equilibrium on postulated gene-disease associations. (2006) (283)
Effects of CCR5- 32, CCR2-64I, and SDF-1 3A Alleles on HIV-1 Disease Progression: An International Meta-Analysis of Individual-Patient Data (2001) (282)
Excess significance bias in the literature on brain volume abnormalities. (2011) (281)
Statins decrease perioperative cardiac complications in patients undergoing noncardiac vascular surgery: the Statins for Risk Reduction in Surgery (StaRRS) study. (2005) (278)
Environmental risk factors and Parkinson's disease: An umbrella review of meta-analyses. (2016) (277)
The False-positive to False-negative Ratio in Epidemiologic Studies (2011) (276)
Mortality risk conferred by small elevations of creatine kinase-MB isoenzyme after percutaneous coronary intervention. (2003) (274)
A universal standard for the validation of blood pressure measuring devices: Association for the Advancement of Medical Instrumentation/European Society of Hypertension/International Organization for Standardization (AAMI/ESH/ISO) Collaboration Statement. (2018) (273)
Enhancing reproducibility for computational methods (2016) (273)
What Other Countries Can Learn From Italy During the COVID-19 Pandemic. (2020) (273)
Assessment of claims of improved prediction beyond the Framingham risk score. (2009) (271)
The Challenge of Reforming Nutritional Epidemiologic Research. (2018) (270)
Collaborative Meta-analysis: Associations of 150 Candidate Genes With Osteoporosis and Osteoporotic Fracture (2009) (267)
Implications of small effect sizes of individual genetic variants on the design and interpretation of genetic association studies of complex diseases. (2006) (266)
Comparisons of established risk prediction models for cardiovascular disease: systematic review (2012) (266)
Issues in comparisons between meta-analyses and large trials. (1998) (265)
Common variants near FRK/COL10A1 and VEGFA are associated with advanced age-related macular degeneration (2011) (264)
Large-scale analysis of association between LRP5 and LRP6 variants and osteoporosis. (2008) (262)
Non-Replication and Inconsistency in the Genome-Wide Association Setting (2007) (261)
What should the genome-wide significance threshold be? Empirical replication of borderline genetic associations. (2012) (260)
Replication in genome-wide association studies. (2009) (258)
External validation of new risk prediction models is infrequent and reveals worse prognostic discrimination. (2015) (257)
The Association between Common Vitamin D Receptor Gene Variations and Osteoporosis: A Participant-Level Meta-Analysis (2006) (254)
A road map for efficient and reliable human genome epidemiology (2006) (252)
Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case–control study (2011) (246)
Meta-assessment of bias in science (2017) (246)
Reproducible Research Practices and Transparency across the Biomedical Literature (2016) (243)
18F-FDG PET for evaluation of bone marrow infiltration in staging of lymphoma: a meta-analysis. (2005) (243)
Comparison of evidence on harms of medical interventions in randomized and nonrandomized studies (2006) (242)
Evaluation of Excess Significance Bias in Animal Studies of Neurological Diseases (2013) (242)
Population-level COVID-19 mortality risk for non-elderly individuals overall and for non-elderly individuals without underlying diseases in pandemic epicenters (2020) (242)
Forecasting for COVID-19 has failed (2020) (241)
Comparison of effect sizes associated with biomarkers reported in highly cited individual articles and in subsequent meta-analyses. (2011) (240)
Implausible results in human nutrition research (2013) (239)
Methodological standards and patient-centeredness in comparative effectiveness research: the PCORI perspective. (2012) (239)
Prognostic Significance of Vascular Endothelial Growth Factor Immunohistochemical Expression in Head and Neck Squamous Cell Carcinoma: A Meta-Analysis (2005) (238)
Improving Validation Practices in “Omics” Research (2011) (235)
The Emergence of Translational Epidemiology: From Scientific Discovery to Population Health Impact (2010) (235)
Assessing scientists for hiring, promotion, and tenure (2018) (231)
A meta-analysis of the relative efficacy and toxicity of Pneumocystis carinii prophylactic regimens. (1996) (230)
Selective reporting biases in cancer prognostic factor studies. (2005) (228)
Effectiveness of antidepressants: an evidence myth constructed from a thousand randomized trials? (2008) (226)
Clinical outcome prediction by microRNAs in human cancer: a systematic review. (2012) (224)
Reporting and interpretation of SF-36 outcomes in randomised trials: systematic review (2009) (223)
Association of Polymorphisms of the Estrogen Receptor α Gene With Bone Mineral Density and Fracture Risk in Women: A Meta‐Analysis (2002) (220)
Benzodiazepines for alcohol withdrawal. (2005) (216)
Exploring the Geometry of Treatment Networks (2008) (216)
Comparative effectiveness of exercise and drug interventions on mortality outcomes: metaepidemiological study (2015) (214)
Empirical evaluation of very large treatment effects of medical interventions. (2012) (214)
Adverse events in randomized trials: neglected, restricted, distorted, and silenced. (2009) (214)
Role of the Fcgamma receptor IIa polymorphism in susceptibility to systemic lupus erythematosus and lupus nephritis: a meta-analysis. (2002) (214)
STrengthening the Reporting of OBservational studies in Epidemiology – Molecular Epidemiology (STROBE-ME): An Extension of the STROBE Statement (2011) (214)
Remission, relapse, and re-remission of proliferative lupus nephritis treated with cyclophosphamide. (2000) (213)
Almost all articles on cancer prognostic markers report statistically significant results. (2007) (212)
Survival with aromatase inhibitors and inactivators versus standard hormonal therapy in advanced breast cancer: meta-analysis. (2006) (211)
A genome-wide association study identifies an osteoarthritis susceptibility locus on chromosome 7q22. (2010) (210)
Persistence of contradicted claims in the literature. (2007) (209)
Meta-research: Evaluation and Improvement of Research Methods and Practices (2015) (208)
When Null Hypothesis Significance Testing Is Unsuitable for Research: A Reassessment (2016) (208)
Accuracy of anti-ribosomal P protein antibody testing for the diagnosis of neuropsychiatric systemic lupus erythematosus: an international meta-analysis. (2006) (205)
Large-scale analysis of association between GDF5 and FRZB variants and osteoarthritis of the hip, knee, and hand. (2009) (203)
Methods for meta-analysis in genetic association studies: a review of their potential and pitfalls (2008) (203)
Life Cycle of Translational Research for Medical Interventions (2008) (199)
More than a billion people taking statins?: Potential implications of the new cardiovascular guidelines. (2014) (198)
The Scientific Foundation for Personal Genomics: Recommendations from a National Institutes of Health–Centers for Disease Control and Prevention Multidisciplinary Workshop (2009) (196)
Evidence-based medicine has been hijacked: a report to David Sackett. (2016) (196)
Evidence Relating Health Care Provider Burnout and Quality of Care (2019) (195)
Physical examination (2003) (194)
Clinically Significant and Biopsy‐Documented Renal Involvement in Primary Sjogren Syndrome (2000) (193)
Machine learning and artificial intelligence research for patient benefit: 20 critical questions on transparency, replicability, ethics, and effectiveness (2020) (192)
Association of Convalescent Plasma Treatment With Clinical Outcomes in Patients With COVID-19: A Systematic Review and Meta-analysis. (2021) (190)
Health outcomes during the 2008 financial crisis in Europe: systematic literature review (2016) (188)
Reversals of established medical practices: evidence to abandon ship. (2012) (188)
Systematic evaluation of the associations between environmental risk factors and dementia: An umbrella review of systematic reviews and meta-analyses (2017) (188)
Rethinking recommendations for screening for depression in primary care (2012) (188)
18F-FDG PET for the diagnosis and grading of soft-tissue sarcoma: a meta-analysis. (2003) (185)
Large-Scale Evidence for the Effect of the COLIA1 Sp1 Polymorphism on Osteoporosis Outcomes: The GENOMOS Study (2006) (185)
Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials (2020) (184)
Overlapping meta-analyses on the same topic: survey of published studies (2013) (182)
Prevalence and outcomes of incidental imaging findings: umbrella review (2018) (181)
Meta-analysis of fractional flow reserve versus quantitative coronary angiography and noninvasive imaging for evaluation of myocardial ischemia. (2007) (180)
Local Literature Bias in Genetic Epidemiology: An Empirical Evaluation of the Chinese Literature (2005) (179)
Drivers of poor medical care (2017) (177)
Intravenous glycoprotein IIb/IIIa receptor antagonists reduce mortality after percutaneous coronary interventions. (2003) (177)
Cytotoxic T-lymphocyte associated antigen 4 gene polymorphisms and autoimmune thyroid disease: a meta-analysis. (2007) (174)
Geographic and Temporal Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted HIV-1 Drug Resistance: An Individual-Patient- and Sequence-Level Meta-Analysis (2015) (173)
UCHL1 is a Parkinson's disease susceptibility gene (2004) (173)
Diagnosis of Parkinson's disease on the basis of clinical and genetic classification: a population-based modelling study (2015) (172)
The GDF5 rs143383 polymorphism is associated with osteoarthritis of the knee with genome-wide statistical significance (2010) (172)
How to use an article about genetic association: B: Are the results of the study valid? (2009) (171)
Reanalyses of randomized clinical trial data. (2014) (170)
Screening performance of first-trimester nuchal translucency for major cardiac defects: a meta-analysis. (2003) (168)
Optimal timing of coronary angiography and potential intervention in non-ST-elevation acute coronary syndromes. (2011) (168)
Small studies are more heterogeneous than large ones: a meta-meta-analysis. (2015) (168)
Extended-interval aminoglycoside administration for children: a meta-analysis. (2004) (167)
Prognostic factors and outcomes for osteosarcoma: an international collaboration. (2009) (167)
Transparency and reproducibility in artificial intelligence (2020) (167)
Lack of evidence to favor specific preventive interventions in psychosis: a network meta‐analysis (2018) (166)
A field synopsis on low-penetrance variants in DNA repair genes and cancer susceptibility. (2009) (164)
Survival and disease-progression benefits with treatment regimens for advanced colorectal cancer: a meta-analysis. (2007) (164)
A standardized citation metrics author database annotated for scientific field (2019) (163)
CTLA-4 gene polymorphisms and susceptibility to type 1 diabetes mellitus: a HuGE Review and meta-analysis. (2005) (162)
Physical activity and cancer: an umbrella review of the literature including 22 major anatomical sites and 770 000 cancer cases (2017) (162)
Technical aspects and inter-laboratory variability in native peptide profiling: the CE-MS experience. (2013) (161)
Meta‐Analysis of Genome‐Wide Scans Provides Evidence for Sex‐ and Site‐Specific Regulation of Bone Mass (2006) (161)
Assessment of vibration of effects due to model specification can demonstrate the instability of observational associations. (2015) (161)
Inadequacies of Physical Examination as a Cause of Medical Errors and Adverse Events: A Collection of Vignettes. (2015) (159)
How does exercise treatment compare with antihypertensive medications? A network meta-analysis of 391 randomised controlled trials assessing exercise and medication effects on systolic blood pressure (2018) (159)
Metformin Does Not Affect Cancer Risk: A Cohort Study in the U.K. Clinical Practice Research Datalink Analyzed Like an Intention-to-Treat Trial (2014) (158)
Effect sizes in cumulative meta-analyses of mental health randomized trials evolved over time. (2004) (156)
Meta-analysis of genome-wide association studies confirms a susceptibility locus for knee osteoarthritis on chromosome 7q22 (2010) (156)
Is everything we eat associated with cancer? A systematic cookbook review. (2013) (155)
Beyond genome-wide association studies: genetic heterogeneity and individual predisposition to cancer. (2010) (155)
Implementation of proteomic biomarkers: making it work (2012) (155)
Reproducible research practices, transparency, and open access data in the biomedical literature, 2015–2017 (2018) (154)
Agreement of treatment effects for mortality from routinely collected data and subsequent randomized trials: meta-epidemiological survey (2016) (153)
Ensuring the integrity of clinical practice guidelines: a tool for protecting patients (2013) (153)
Cyclophosphamide with low or high dose prednisolone for systemic sclerosis lung disease. (2002) (152)
Meta-analysis of the association of beta2-adrenergic receptor polymorphisms with asthma phenotypes. (2005) (152)
Research grants: Conform and be funded (2012) (150)
Intravenous immunoglobulin compared with cyclophosphamide for proliferative lupus nephritis (1999) (149)
Narrow band imaging to differentiate neoplastic and non-neoplastic colorectal polyps in real time: a meta-analysis of diagnostic operating characteristics (2013) (149)
Radiotherapy vs. nonsteroidal anti-inflammatory drugs for the prevention of heterotopic ossification after major hip procedures: a meta-analysis of randomized trials. (2004) (148)
Design and analysis of metabolomics studies in epidemiologic research: a primer on -omic technologies. (2014) (147)
Nuchal translucency and fetal cardiac defects: a pooled analysis of major fetal echocardiography centers. (2005) (144)
Expectant, Medical, or Surgical Management of First-Trimester Miscarriage: A Meta-Analysis (2005) (144)
Genome-Wide Association Studies, Field Synopses, and the Development of the Knowledge Base on Genetic Variation and Human Diseases (2009) (144)
The Fc gamma RIIIA-F158 allele is a risk factor for the development of lupus nephritis: a meta-analysis. (2003) (143)
Claims of sex differences: an empirical assessment in genetic associations. (2007) (142)
Data sharing and reanalysis of randomized controlled trials in leading biomedical journals with a full data sharing policy: survey of studies published in The BMJ and PLOS Medicine (2018) (142)
Real-world evidence: How pragmatic are randomized controlled trials labeled as pragmatic? (2018) (141)
Development of the Instrument to assess the Credibility of Effect Modification Analyses (ICEMAN) in randomized controlled trials and meta-analyses (2020) (141)
Multiple-treatments meta-analysis of chemotherapy and targeted therapies in advanced breast cancer. (2008) (141)
Survival benefits with diverse chemotherapy regimens for ovarian cancer: meta-analysis of multiple treatments. (2006) (141)
Impact of Schizophrenia Candidate Genes on Schizotypy and Cognitive Endophenotypes at the Population Level (2007) (140)
Origin and funding of the most frequently cited papers in medicine: database analysis (2006) (140)
Head-to-head randomized trials are mostly industry sponsored and almost always favor the industry sponsor. (2015) (140)
STrengthening the Reporting of OBservational studies in Epidemiology - Molecular Epidemiology (STROBE-ME): an extension of the STROBE statement. (2011) (140)
Infection fatality rate of COVID-19 inferred from seroprevalence data (2020) (140)
Mapping risk factors for depression across the lifespan: An umbrella review of evidence from meta-analyses and Mendelian randomization studies. (2018) (139)
Vaccination in adult patients with auto-immune inflammatory rheumatic diseases: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for vaccination in adult patients with auto-immune inflammatory rheumatic diseases. (2011) (139)
Materializing research promises: opportunities, priorities and conflicts in translational medicine (2004) (138)
A heterogeneity-based genome search meta-analysis for autism-spectrum disorders (2006) (138)
Autoimmune hemolytic anemia in patients with systemic lupus erythematosus. (2000) (138)
Understanding and harnessing the health effects of rapid urbanization in China. (2011) (138)
Statistically significant meta-analyses of clinical trials have modest credibility and inflated effects. (2011) (138)
Double Versus Single Stenting for Coronary Bifurcation Lesions: A Meta-Analysis (2009) (137)
p-Curve and p-Hacking in Observational Research (2016) (137)
Anaemia in systemic lupus erythematosus: aetiological profile and the role of erythropoietin (2000) (137)
Assessing mandatory stay‐at‐home and business closure effects on the spread of COVID‐19 (2021) (136)
Association of GSTM1, GSTT1, and GSTP1 gene polymorphisms with the risk of prostate cancer: a meta-analysis. (2005) (135)
Meta‐research: The art of getting it wrong (2010) (135)
Effects of CCR5-Delta32, CCR2-64I, and SDF-1 3'A alleles on HIV-1 disease progression: An international meta-analysis of individual-patient data. (2001) (133)
Large-scale replication and heterogeneity in Parkinson disease genetic loci (2012) (133)
Limitations are not properly acknowledged in the scientific literature. (2007) (132)
On the synthesis and interpretation of consistent but weak gene-disease associations in the era of genome-wide association studies. (2007) (132)
A meta-analysis of genome-wide association studies identifies novel variants associated with osteoarthritis of the hip (2013) (132)
The Predictive Approaches to Treatment effect Heterogeneity (PATH) Statement (2019) (132)
Insights into the genetic architecture of osteoarthritis from stage 1 of the arcOGEN study (2010) (131)
Is molecular profiling ready for use in clinical decision making? (2007) (130)
Electrocardiogram-gated single-photon emission computed tomography versus cardiac magnetic resonance imaging for the assessment of left ventricular volumes and ejection fraction: a meta-analysis. (2002) (129)
Meta-analysis methods. (2008) (129)
Next-generation systematic reviews: prospective meta-analysis, individual-level data, networks and umbrella reviews (2017) (129)
Evolution and Translation of Research Findings: From Bench to Where? (2006) (128)
Atherosclerosis in premenopausal women with antiphospholipid syndrome and systemic lupus erythematosus: a controlled study. (2003) (125)
Are amoxycillin and folate inhibitors as effective as other antibiotics for acute sinusitis? A meta-analysis (1998) (125)
US studies may overestimate effect sizes in softer research (2013) (124)
Systematic evaluation of environmental factors: persistent pollutants and nutrients correlated with serum lipid levels (2012) (124)
Meta-research: Why research on research matters (2018) (123)
A Nutrient-Wide Association Study on Blood Pressure (2012) (122)
Exploration, Inference, and Prediction in Neuroscience and Biomedicine (2019) (121)
A network of investigator networks in human genome epidemiology. (2005) (121)
Thousands of scientists publish a paper every five days (2018) (121)
Required sample size and nonreplicability thresholds for heterogeneous genetic associations (2008) (119)
How to use an article about genetic association: A: Background concepts. (2009) (118)
Recalibrating the Use of Race in Medical Research. (2021) (118)
International ranking systems for universities and institutions: a critical appraisal (2007) (118)
Association of polymorphisms of the oestrogen receptor α gene with the age of menarche (2002) (118)
Assessment of Osteoarthritis Candidate Genes in a Meta-Analysis of Nine Genome-Wide Association Studies (2014) (117)
The 10-Item Standardized Cosmesis and Health Nasal Outcomes Survey (SCHNOS) for Functional and Cosmetic Rhinoplasty (2017) (116)
Transforming Epidemiology for 21st Century Medicine and Public Health (2013) (116)
Predicting death: an empirical evaluation of predictive tools for mortality. (2011) (116)
Methods to increase reproducibility in differential gene expression via meta-analysis (2016) (115)
The power of meta-analysis in genome-wide association studies. (2013) (115)
Clinical efficacy of high-dose acyclovir in patients with human immunodeficiency virus infection: a meta-analysis of randomized individual patient data. (1998) (115)
Replication of past candidate loci for common diseases and phenotypes in 100 genome-wide association studies (2010) (114)
Equivalency of the diagnostic accuracy of the PHQ-8 and PHQ-9: a systematic review and individual participant data meta-analysis (2019) (114)
Effects of interventions on survival in acute respiratory distress syndrome: an umbrella review of 159 published randomized trials and 29 meta-analyses (2014) (114)
Global perspective of COVID‐19 epidemiology for a full‐cycle pandemic (2020) (114)
More time for research: Fund people not projects (2011) (113)
A Universal Standard for the Validation of Blood Pressure Measuring Devices: Association for the Advancement of Medical Instrumentation/European Society of Hypertension/International Organization for Standardization (AAMI/ESH/ISO) Collaboration Statement. (2018) (113)
Large-scale GWAS identifies multiple loci for hand grip strength providing biological insights into muscular fitness (2017) (113)
Modelling science trustworthiness under publish or perish pressure (2017) (113)
Extrapolating from Animals to Humans (2012) (112)
Selection in Reported Epidemiological Risks: An Empirical Assessment (2007) (112)
Estimates of the Continuously Publishing Core in the Scientific Workforce (2014) (112)
The Emergence of Networks in Human Genome Epidemiology: Challenges and Opportunities (2007) (112)
Comprehensive field synopsis and systematic meta-analyses of genetic association studies in cutaneous melanoma. (2011) (111)
The association of depression and all-cause and cause-specific mortality: an umbrella review of systematic reviews and meta-analyses (2018) (111)
Clarifications on the application and interpretation of the test for excess significance and its extensions (2013) (111)
Commentary: meta-analysis of individual participants' data in genetic epidemiology. (2002) (111)
Does screening for disease save lives in asymptomatic adults? Systematic review of meta-analyses and randomized trials. (2015) (111)
Enhancing the usability of systematic reviews by improving the consideration and description of interventions (2017) (110)
SARS‐CoV‐2 re‐infection risk in Austria (2021) (110)
Comparative survival with diverse chemotherapy regimens for cancer of unknown primary site: multiple-treatments meta-analysis. (2009) (109)
Bias in associations of emerging biomarkers with cardiovascular disease. (2013) (107)
Number of published systematic reviews and global burden of disease: database analysis (2003) (107)
The association of P‐glycoprotein with response to chemotherapy and clinical outcome in patients with osteosarcoma (2003) (107)
COVID-19 antibody seroprevalence in Santa Clara County, California (2021) (107)
Potential Reporting Bias in fMRI Studies of the Brain (2013) (107)
Attention to Local Health Burden and the Global Disparity of Health Research (2014) (107)
What Happens When Underperforming Big Ideas in Research Become Entrenched? (2016) (106)
Establishment of genetic associations for complex diseases is independent of early study findings (2004) (106)
A generalized view of self-citation: direct, co-author, collaborative, and coercive induced self-citation. (2015) (106)
Routinely collected data and comparative effectiveness evidence: promises and limitations (2016) (105)
Relation between burden of disease and randomised evidence in sub-Saharan Africa: survey of research (2002) (105)
A multi-centre clinico-genetic analysis of the VPS35 gene in Parkinson disease indicates reduced penetrance for disease-associated variants (2012) (105)
Strengthening the reporting of genetic association studies (STREGA): an extension of the strengthening the reporting of observational studies in epidemiology (STROBE) statement. (2009) (105)
Waste, Leaks, and Failures in the Biomarker Pipeline. (2017) (105)
Systematic evaluation of environmental and behavioural factors associated with all-cause mortality in the United States national health and nutrition examination survey. (2013) (104)
Patient Outcomes with Teaching Versus Nonteaching Healthcare: A Systematic Review (2006) (104)
STrengthening the REporting of Genetic Association Studies (STREGA)—an extension of the STROBE statement (2009) (104)
STrengthening the REporting of Genetic Association studies (STREGA) – an extension of the STROBE statement (2009) (103)
Effect of chemokine receptor gene polymorphisms on the response to potent antiretroviral therapy (2000) (103)
Meta-analysis comparing drug-eluting stents with bare metal stents. (2005) (103)
MINIMAR (MINimum Information for Medical AI Reporting): Developing reporting standards for artificial intelligence in health care (2020) (103)
Predictors of sustained amenorrhea from pulsed intravenous cyclophosphamide in premenopausal women with systemic lupus erythematosus. (2002) (102)
Effects of CCR5-Δ32 and CCR2-64I alleles on HIV-1 disease progression: the protection varies with duration of infection (2003) (102)
Systematic identification of interaction effects between genome- and environment-wide associations in type 2 diabetes mellitus (2013) (102)
Association of the CYP17 gene polymorphism with the risk of prostate cancer: a meta-analysis. (2003) (102)
Pediatric Versus Adult Drug Trials for Conditions With High Pediatric Disease Burden (2012) (102)
Sample size evolution in neuroimaging research: An evaluation of highly-cited studies (1990–2012) and of latest practices (2017–2018) in high-impact journals (2020) (102)
Association of C677T polymorphism in the methylenetetrahydrofolate reductase gene with hypertension in pregnancy and pre-eclampsia: a meta-analysis (2004) (101)
Strengthening the reporting of genetic risk prediction studies: the GRIPS statement (2011) (101)
Anticonvulsants for alcohol withdrawal. (2005) (101)
Making Prospective Registration of Observational Research a Reality (2014) (100)
Reporting of safety data from randomised trials (1998) (100)
Potential Reporting Bias in Neuroimaging Studies of Sex Differences (2018) (100)
Bibliometrics: Is your most cited work your best? (2014) (100)
Risk factors for central nervous system involvement in systemic lupus erythematosus. (2000) (99)
Meta-analyses with industry involvement are massively published and report no caveats for antidepressants. (2016) (99)
Long noncoding RNAs as novel predictors of survival in human cancer: a systematic review and meta-analysis (2016) (99)
Quality of reporting of cancer prognostic marker studies: association with reported prognostic effect. (2007) (99)
Predictors of clinical outcome and radiologic progression in patients with neuropsychiatric manifestations of systemic lupus erythematosus. (2000) (99)
CYP2D6 polymorphisms and the risk of tardive dyskinesia in schizophrenia: a meta-analysis (2005) (98)
Nature, Nurture, and Cancer Risks: Genetic and Nutritional Contributions to Cancer. (2017) (98)
Updated science-wide author databases of standardized citation indicators (2020) (97)
Association of Collagen Iα 1 Sp1 Polymorphism with the Risk of Prevalent Fractures: A Meta‐Analysis (2001) (97)
Vitamin D receptor gene polymorphisms and risk of prostate cancer: a meta-analysis. (2003) (97)
Prediction of Cardiovascular Disease Outcomes and Established Cardiovascular Risk Factors by Genome-Wide Association Markers (2009) (97)
SARS-CoV-2 reinfections: Overview of efficacy and duration of natural and hybrid immunity (2022) (97)
Concentration of the Most-Cited Papers in the Scientific Literature: Analysis of Journal Ecosystems (2006) (97)
Inflated numbers of authors over time have not been just due to increasing research complexity. (2008) (96)
Lack of replication of thirteen single-nucleotide polymorphisms implicated in Parkinson's disease: a large-scale international study (2006) (96)
Industry sponsorship and selection of comparators in randomized clinical trials (2010) (96)
Power failure: why small sample size undermines the reliability of neuroscience (2013) (96)
Evaluating novel agent effects in multiple‐treatments meta‐regression (2010) (95)
There are no randomized controlled trials that support the United States Preventive Services Task Force guideline on screening for depression in primary care: a systematic review (2014) (95)
Informed Consent, Big Data, and the Oxymoron of Research That Is Not Research (2013) (95)
Second versus first wave of COVID-19 deaths: Shifts in age distribution and in nursing home fatalities (2020) (95)
Mapping the universe of registered reports (2018) (95)
Effectiveness and harms of seasonal and pandemic influenza vaccines in children, adults and elderly (2012) (94)
Sample size evolution in neuroimaging research: an evaluation of highly-cited studies (1990-2012) and of latest practices (2017-2018) in high-impact journals (2019) (94)
Evidence report on the treatment of pain in cancer patients. (2004) (94)
Indirect comparisons: the mesh and mess of clinical trials (2006) (94)
Preventive psychiatry: a blueprint for improving the mental health of young people (2021) (94)
Evaluation of Evidence of Statistical Support and Corroboration of Subgroup Claims in Randomized Clinical Trials (2017) (93)
What Have We (Not) Learnt from Millions of Scientific Papers with P Values? (2019) (93)
New clinical trial designs in the era of precision medicine: An overview of definitions, strengths, weaknesses, and current use in oncology. (2019) (93)
Total and cause-specific mortality before and after the onset of the Greek economic crisis: an interrupted time-series analysis. (2016) (93)
Large-scale analysis of association between polymorphisms in the transforming growth factor beta 1 gene (TGFB1) and osteoporosis: the GENOMOS study. (2008) (92)
Independent and joint effects of the MAPT and SNCA genes in Parkinson disease (2011) (92)
Meta-Analysis of the Immunogenicity and Tolerability of Pandemic Influenza A 2009 (H1N1) Vaccines (2011) (92)
Undue industry influences that distort healthcare research, strategy, expenditure and practice: a review (2013) (92)
SRD5A2 gene polymorphisms and the risk of prostate cancer: a meta-analysis. (2003) (92)
Comparative Efficacy and Acceptability of 21 Antidepressant Drugs for the Acute Treatment of Adults With Major Depressive Disorder: A Systematic Review and Network Meta-Analysis. (2018) (91)
Patient Health Questionnaire-9 scores do not accurately estimate depression prevalence: individual participant data meta-analysis. (2020) (91)
Why Most Published Research Findings Are False: Author's Reply to Goodman and Greenland (2007) (91)
Are medical conferences useful? And for whom? (2012) (91)
What makes a good predictor?: the evidence applied to coronary artery calcium score. (2010) (90)
Early or Deferred Zidovudine Therapy in HIV-Infected Patients without an AIDS-Defining Illness (1995) (90)
Exposure‐wide epidemiology: revisiting Bradford Hill (2016) (90)
Studying the elusive environment in large scale. (2014) (90)
Consistency of genome-wide associations across major ancestral groups (2012) (90)
Patterns of patient enrollment in randomized controlled trials. (2001) (89)
Academic criteria for promotion and tenure in biomedical sciences faculties: cross sectional analysis of international sample of universities (2020) (89)
Diagnostic performance of coronary magnetic resonance angiography as compared against conventional X-ray angiography: a meta-analysis. (2004) (88)
Assessing value in biomedical research: the PQRST of appraisal and reward. (2014) (88)
Validation of the Greek translation of the Dundee Ready Education Environment Measure (DREEM). (2010) (87)
Recursive cumulative meta-analysis: a diagnostic for the evolution of total randomized evidence from group and individual patient data. (1999) (87)
Association between maternal and infant class I and II HLA alleles and of their concordance with the risk of perinatal HIV type 1 transmission. (2002) (87)
Placing epidemiological results in the context of multiplicity and typical correlations of exposures (2014) (87)
Identification and Catheter Ablation of Extracardiac and Intracardiac Components of Ligament of Marshall Tissue for Treatment of Paroxysmal Atrial Fibrillation (2001) (86)
Corticosteroids for preventing neonatal respiratory morbidity after elective caesarean section at term. (2018) (85)
Poor performance of clinical prediction models: the harm of commonly applied methods. (2017) (85)
How to survive the medical misinformation mess (2017) (85)
An empirical assessment of validation practices for molecular classifiers (2011) (84)
How to design preclinical studies in nanomedicine and cell therapy to maximize the prospects of clinical translation (2018) (84)
Home blood pressure as a cardiovascular outcome predictor: it's time to take this method seriously. (2010) (84)
Critical interpretation of Cochran's Q test depends on power and prior assumptions about heterogeneity (2010) (84)
Researching Genetic Versus Nongenetic Determinants of Disease: A Comparison and Proposed Unification (2009) (84)
Should governments continue lockdown to slow the spread of covid-19? (2020) (83)
Diagnostic Performance of Intracardiac Echogenic Foci for Down Syndrome: A Meta‐analysis (2003) (83)
How to use an article about genetic association: C: What are the results and will they help me in caring for my patients? (2009) (83)
Meta-Analysis Comparing Established Risk Prediction Models (EuroSCORE II, STS Score, and ACEF Score) for Perioperative Mortality During Cardiac Surgery. (2016) (82)
Unavailability of online supplementary scientific information from articles published in major journals (2005) (81)
A compendium of genome-wide associations for cancer: critical synopsis and reappraisal. (2010) (81)
Heritability and genome-wide association study to assess genetic differences between advanced age-related macular degeneration subtypes. (2012) (81)
What's to Know About the Credibility of Empirical Economics? (2013) (80)
Recommendations and Practical Guidance for performing and reporting validation studies according to the Universal Standard for the validation of blood pressure measuring devices by the Association for the Advancement of Medical Instrumentation/European Society of Hypertension/International Organizat (2019) (80)
Any casualties in the clash of randomised and observational evidence? (2001) (80)
Science mapping analysis characterizes 235 biases in biomedical research. (2010) (80)
Falsified papers in high-impact journals were slow to retract and indistinguishable from nonfraudulent papers. (2008) (80)
Improving Safety Reporting from Randomised Trials (2002) (79)
The need to consider the wider agenda in systematic reviews and meta-analyses: breadth, timing, and depth of the evidence (2010) (79)
Biomarker failures. (2013) (79)
Diagnosis and Treatment of Hypertension in the 2017 ACC/AHA Guidelines and in the Real World. (2018) (78)
Finding the power to reduce publication bias (2017) (78)
Safety reporting in randomized trials of mental health interventions. (2004) (78)
Association of Leiden mutation in Factor V gene with hypertension in pregnancy and pre-eclampsia: a meta-analysis (2003) (78)
Prognostic Significance of TP53 Tumor Suppressor Gene Expression and Mutations in Human Osteosarcoma (2004) (78)
Evaluation of Wellness Determinants and Interventions by Citizen Scientists. (2015) (77)
Risk factors for posttraumatic stress disorder: An umbrella review of systematic reviews and meta-analyses (2019) (77)
Altmetric Scores, Citations, and Publication of Studies Posted as Preprints (2018) (77)
Can quality of clinical trials and meta-analyses be quantified? (1998) (76)
In the Era of Precision Medicine and Big Data, Who Is Normal? (2018) (76)
Percutaneous coronary intervention for late reperfusion after myocardial infarction in stable patients. (2007) (76)
Quantifying rare, deleterious variation in 12 human cytochrome P450 drug-metabolism genes in a large-scale exome dataset. (2014) (76)
Routinely collected data for randomized trials: promises, barriers, and implications (2018) (76)
Availability of large-scale evidence on specific harms from systematic reviews of randomized trials. (2004) (75)
Generic versus brand-name drugs used in cardiovascular diseases (2015) (75)
Non-publication and delayed publication of randomized trials on vaccines: survey (2014) (75)
Confidence and precision increase with high statistical power (2013) (75)
The diagnostic accuracy of the Patient Health Questionnaire-2 (PHQ-2), Patient Health Questionnaire-8 (PHQ-8), and Patient Health Questionnaire-9 (PHQ-9) for detecting major depression: protocol for a systematic review and individual patient data meta-analyses (2014) (74)
Early mortality and morbidity of bilateral versus single internal thoracic artery revascularization: propensity and risk modeling. (2001) (74)
Prosthesis infection: diagnosis after total joint arthroplasty with antigranulocyte scintigraphy with 99mTc-labeled monoclonal antibodies--a meta-analysis. (2007) (74)
Prognostic factors and clustering of serious clinical outcomes in antiphospholipid syndrome. (2000) (74)
Evaluation of excess statistical significance in meta-analyses of 98 biomarker associations with cancer risk. (2012) (74)
Clinical trials: what a waste (2014) (74)
A large-scale genetic association study to evaluate the contribution of Omi/HtrA2 (PARK13) to Parkinson's disease (2011) (74)
A systematic review of the genetic mechanisms of dolutegravir resistance (2019) (73)
Heterogeneity of the baseline risk within patient populations of clinical trials: a proposed evaluation algorithm. (1998) (72)
Measuring Co-Authorship and Networking-Adjusted Scientific Impact (2008) (72)
Multiple Citation Indicators and Their Composite across Scientific Disciplines (2016) (72)
Dynamics of co-authorship and productivity across different fields of scientific research (2018) (71)
Replication and meta-analysis of TMEM132D gene variants in panic disorder (2012) (71)
Content area experts as authors: helpful or harmful for systematic reviews and meta-analyses? (2012) (71)
Strengthening the reporting of genetic association studies (STREGA): an extension of the STROBE Statement (2009) (71)
An empirical assessment of transparency and reproducibility-related research practices in the social sciences (2014–2017) (2020) (71)
Acknowledging and Overcoming Nonreproducibility in Basic and Preclinical Research. (2017) (70)
STrengthening the reporting of OBservational studies in Epidemiology—Molecular Epidemiology (STROBE-ME): an extension of the STROBE statement (2011) (69)
Diet, body size, physical activity and risk of prostate cancer: An umbrella review of the evidence. (2016) (69)
A consensus-based transparency checklist (2019) (69)
STrengthening the Reporting of OBservational studies in Epidemiology--Molecular Epidemiology (STROBE-ME): an extension of the STROBE statement. (2011) (68)
Minimal and null predictive effects for the most popular blood biomarkers of cardiovascular disease. (2012) (68)
Risk factors and interventions with statistically significant tiny effects. (2011) (68)
The Importance of Predefined Rules and Prespecified Statistical Analyses: Do Not Abandon Significance. (2019) (68)
Adverse Events: The More You Search, the More You Find (2006) (68)
Pathways for inappropriate dispensing of antibiotics for rhinosinusitis: a randomized trial. (2001) (68)
Family-Based versus Unrelated Case-Control Designs for Genetic Associations (2006) (67)
Evaluation of cluster randomized controlled trials in sub-Saharan Africa. (2003) (67)
Scientific inbreeding and same-team replication: type D personality as an example. (2012) (67)
Prognostic effect size of cardiovascular biomarkers in datasets from observational studies versus randomised trials: meta-epidemiology study (2011) (67)
The importance of potential studies that have not existed and registration of observational data sets. (2012) (67)
Commentary: grading the credibility of molecular evidence for complex diseases. (2006) (66)
Observational studies often make clinical practice recommendations: an empirical evaluation of authors' attitudes. (2013) (66)
Assessing the Evolution of Effect Sizes over Time (2006) (66)
The Accuracy of the Patient Health Questionnaire-9 Algorithm for Screening to Detect Major Depression: An Individual Participant Data Meta-Analysis (2019) (66)
Comparative effect sizes in randomised trials from less developed and more developed countries: meta-epidemiological assessment (2013) (66)
Journals Should Publish All “Null” Results and Should Sparingly Publish “Positive” Results (2006) (66)
Reconciling estimates of global spread and infection fatality rates of COVID‐19: An overview of systematic evaluations (2021) (65)
Engaging Patients and Stakeholders in Research Proposal Review: The Patient-Centered Outcomes Research Institute (2014) (65)
Mortality and Paclitaxel-Coated Devices (2020) (65)
How good is "evidence" from clinical studies of drug effects and why might such evidence fail in the prediction of the clinical utility of drugs? (2015) (65)
Global estimates of high‐level brain drain and deficit (2004) (65)
The DOT1L rs12982744 polymorphism is associated with osteoarthritis of the hip with genome-wide statistical significance in males (2013) (64)
The Predictive Approaches to Treatment effect Heterogeneity (PATH) Statement: Explanation and Elaboration (2019) (64)
Genetic association studies in pre-eclampsia: systematic meta-analyses and field synopsis. (2012) (64)
Maternal cell-free viremia in the natural history of perinatal HIV-1 transmission: a meta-analysis. (1998) (63)
Synopsis of Preterm Birth Genetic Association Studies: The Preterm Birth Genetics Knowledge Base (PTBGene) (2010) (63)
Validation and Utility Testing of Clinical Prediction Models: Time to Change the Approach. (2020) (63)
A Genome-Wide Association Study Identifies an Osteoarthritis Susceptibility Locus on Chromosome 7 q 22 (2010) (63)
Overinterpretation of clinical applicability in molecular diagnostic research. (2009) (63)
Meta-analysis of Voxel-Based Neuroimaging Studies using Seed-based d Mapping with Permutation of Subject Images (SDM-PSI). (2019) (62)
Beyond genomics: understanding exposotypes through metabolomics (2018) (62)
Effect of formal statistical significance on the credibility of observational associations. (2008) (62)
Right ventricular diastolic dysfunction in patients with anticardiolipin antibodies and antiphospholipid syndrome (2001) (62)
Underlying genetic models of inheritance in established type 2 diabetes associations. (2009) (62)
An overview of methods for network meta-analysis using individual participant data: when do benefits arise? (2018) (61)
Discovery properties of genome-wide association signals from cumulatively combined data sets. (2009) (61)
Associations of polymorphisms of eight muscle- or metabolism-related genes with performance in Mount Olympus marathon runners. (2010) (61)
Raw data from clinical trials: within reach? (2013) (60)
Genetic effects on HIV disease progression (1998) (60)
Spectrum and significance of bacteremia due to Moraxella catarrhalis. (1995) (60)
Use of reclassification for assessment of improved prediction: an empirical evaluation. (2011) (59)
Prevention and management of non-communicable disease: the IOC consensus statement, Lausanne 2013 (2013) (59)
Polymorphisms in the 5′ flank of COL1A1 gene and osteoporosis: meta-analysis of published studies (2011) (59)
Synthesis of observational studies should consider credibility ceilings. (2009) (59)
Personalized Genetic Prediction: Too Limited, Too Expensive, or Too Soon? (2009) (59)
Vitamin D receptor gene BsmI and TaqI polymorphisms and fracture risk: a meta-analysis. (2006) (59)
Simple, standardized incorporation of genetic risk into non-genetic risk prediction tools for complex traits: coronary heart disease as an example (2014) (59)
Expectations, validity, and reality in omics. (2010) (59)
Gender-related variables for health research (2020) (59)
Curbing Unnecessary and Wasted Diagnostic Imaging. (2019) (59)
The effects of excluding treatments from network meta-analyses: survey (2013) (58)
An epidemic of false claims. Competition and conflicts of interest distort too many medical findings. (2011) (58)
Correction: Geographic and Temporal Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted HIV-1 Drug Resistance: An Individual-Patient- and Sequence-Level Meta-Analysis (2015) (57)
Association of polymorphisms of the oestrogen receptor alpha gene with the age of menarche. (2002) (57)
Limitations and Misinterpretations of E-Values for Sensitivity Analyses of Observational Studies (2019) (57)
The effectiveness of long-term psychoanalytic psychotherapy--a meta-analysis of randomized controlled trials. (2012) (57)
Diagnostic tests often fail to lead to changes in patient outcomes. (2014) (57)
Obtaining evidence by a single well-powered trial or several modestly powered trials (2016) (57)
Extreme between-study homogeneity in meta-analyses could offer useful insights. (2006) (56)
Outcome reporting bias in clinical trials: why monitoring matters (2017) (56)
The role of FcγRIIA and IIIA polymorphisms in autoimmune diseases (2004) (56)
Perspective: Limiting Dependence on Nonrandomized Studies and Improving Randomized Trials in Human Nutrition Research: Why and How. (2018) (56)
Patient Safety Strategies Targeted at Diagnostic Errors (2013) (56)
Predictors and impact of losses to follow-up in an HIV-1 perinatal transmission cohort in Malawi. (1999) (55)
Design and Analysis for Studying microRNAs in Human Disease: A Primer on -Omic Technologies. (2014) (55)
Genetic effects versus bias for candidate polymorphisms in myocardial infarction: case study and overview of large-scale evidence. (2007) (54)
Effects of CCR5-Δ32 and CCR2-64I alleles on disease progression of perinatally HIV-1-infected children: an international meta-analysis (2003) (54)
Reporting of conflicts of interest in guidelines of preventive and therapeutic interventions (2001) (54)
Perspective: Improving Nutritional Guidelines for Sustainable Health Policies: Current Status and Perspectives (2017) (54)
An empirical evaluation of multifarious outcomes in pharmacogenetics: beta-2 adrenoceptor gene polymorphisms in asthma treatment (2006) (54)
Multivariate models of self-reported health often neglected essential candidate determinants and methodological issues. (2005) (53)
Human Genome Sequencing at the Population Scale: A Primer on High-Throughput DNA Sequencing and Analysis (2017) (53)
Are systematic reviews and meta-analyses still useful research? We are not sure (2018) (53)
Role of the Fcgamma receptor IIA polymorphism in the antiphospholipid syndrome: an international meta-analysis. (2003) (53)
Quantifying Selective Reporting and the Proteus Phenomenon for Multiple Datasets with Similar Bias (2011) (53)
Practices and impact of primary outcome adjustment in randomized controlled trials: meta-epidemiologic study (2013) (53)
Evidence of reporting biases in voxel‐based morphometry (VBM) studies of psychiatric and neurological disorders (2013) (52)
The relationship between study design, results, and reporting of randomized clinical trials of HIV infection. (1997) (52)
Perfect study, poor evidence: interpretation of biases preceding study design. (2008) (52)
Meta-analysis for ranked discovery datasets: Theoretical framework and empirical demonstration for microarrays (2008) (52)
Mortality in systemic sclerosis. (2008) (52)
Systematic reviews: guidance relevant for studies of older people (2017) (52)
Limited benefit of antiretroviral resistance testing in treatment-experienced patients: a meta-analysis (2004) (52)
Exclusion of Elderly People from Randomized Clinical Trials of Drugs for Ischemic Heart Disease (2017) (52)
Maternal viral load and rate of disease progression among vertically HIV-1-infected children: an international meta-analysis (2003) (52)
The efficacy of psychotherapies and pharmacotherapies for mental disorders in adults: an umbrella review and meta‐analytic evaluation of recent meta‐analyses (2022) (51)
Is widespread screening for hepatitis C justified? (2015) (51)
Meta‐analyses identify differentially expressed microRNAs in Parkinson's disease (2019) (51)
Corticosteroids for preventing neonatal respiratory morbidity after elective caesarean section at term. (2009) (51)
An epidemic of false claims. (2011) (51)
Association between obesity and postoperative atrial fibrillation in patients undergoing cardiac operations: a systematic review and meta-analysis. (2013) (51)
Immunomodulatory Effects of Voriconazole on Monocytes Challenged with Aspergillus fumigatus: Differential Role of Toll-Like Receptors (2008) (51)
Evidence on interventions to reduce medical errors (2001) (51)
Circulating autoantibodies to erythropoietin are associated with human immunodeficiency virus type 1-related anemia. (1999) (51)
Meta-Analysis in Genome-Wide Association Datasets: Strategies and Application in Parkinson Disease (2007) (51)
Citation Metrics: A Primer on How (Not) to Normalize (2016) (50)
Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration (2011) (50)
Timing and Characteristics of Cumulative Evidence Available on Novel Therapeutic Agents Receiving Food and Drug Administration Accelerated Approval (2017) (49)
Expression of Immunomodulatory Genes in Human Monocytes Induced by Voriconazole in the Presence of Aspergillus fumigatus (2006) (49)
Systematic examination of preprint platforms for use in the medical and biomedical sciences setting (2020) (49)
Immunogenicity and adverse events of avian influenza A H5N1 vaccine in healthy adults: multiple-treatments meta-analysis. (2009) (49)
Meta-analysis of the association of the cathepsin D Ala224Val gene polymorphism with the risk of Alzheimer's disease: a HuGE gene-disease association review. (2004) (49)
Genome-wide significant associations for variants with minor allele frequency of 5% or less--an overview: A HuGE review. (2010) (49)
New Prognostic Markers for Outcome of Acute Pancreatitis: Overview of Reporting in 184 Studies (2011) (48)
Accuracy of Smartphone Camera Applications for Detecting Atrial Fibrillation (2020) (48)
Conduction Delay Within the Coronary Sinus in Humans: Implications for Atrial Arrhythmias (2002) (48)
Stealth research: is biomedical innovation happening outside the peer-reviewed literature? (2015) (48)
Estimating the Prevalence of Transparency and Reproducibility-Related Research Practices in Psychology (2014–2017) (2021) (48)
Individualized Cost-Effectiveness Analysis (2011) (48)
Sex based subgroup differences in randomized controlled trials: empirical evidence from Cochrane meta-analyses (2016) (48)
Assessment of transparency indicators across the biomedical literature: How open is open? (2020) (47)
Call to improve transparency of trials of non-regulated interventions (2015) (47)
A user’s guide to inflated and manipulated impact factors (2019) (47)
Predictive modeling and heterogeneity of baseline risk in meta-analysis of individual patient data. (2001) (47)
Environmental risk factors and nonpharmacological and nonsurgical interventions for obesity: An umbrella review of meta‐analyses of cohort studies and randomized controlled trials (2018) (47)
C-Reactive protein concentrations and angiographic characteristics of coronary lesions. (2001) (47)
Short-term economic impact of the Zika virus outbreak. (2016) (46)
Biologic agents in rheumatology: unmet issues after 200 trials and $200 billion sales (2013) (46)
Disclosures in Nutrition Research: Why It Is Different. (2017) (46)
A case study in model failure? COVID-19 daily deaths and ICU bed utilisation predictions in New York state (2020) (46)
The Sp1 COLIA1 Gene Polymorphism, and Not Vitamin D Receptor or Estrogen Receptor Gene Polymorphisms, Determines Bone Mineral Density in Postmenopausal Greek Women (2001) (46)
Are adaptive randomised trials or non-randomised studies the best way to address the Ebola outbreak in west Africa? (2015) (46)
Probability of major depression diagnostic classification using semi-structured versus fully structured diagnostic interviews (2018) (46)
Calibrating the Scientific Ecosystem Through Meta-Research (2019) (46)
An empirical assessment of transparency and reproducibility-related research practices in the social sciences (2014-2017) (2019) (45)
Professional Societies Should Abstain From Authorship of Guidelines and Disease Definition Statements. (2018) (45)
Preoperative prediction of long-term survival after coronary artery bypass grafting in patients with low left ventricular ejection fraction. (2005) (45)
Standardized retrieval of side effects data for meta-analysis of safety outcomes. A feasibility study in acute sinusitis. (2002) (45)
Effect of diastolic dysfunction on postoperative outcomes after cardiovascular surgery: A systematic review and meta-analysis. (2016) (45)
The Geometric Increase in Meta-Analyses from China in the Genomic Era (2013) (45)
Recommendations and proposed guidelines for assessing the cumulative evidence on joint effects of genes and environments on cancer occurrence in humans. (2012) (45)
Challenges in meta-analysis of randomized clinical trials for rare harmful cardiovascular events: the case of rosiglitazone. (2008) (45)
Immunogenicity and safety of the multicomponent meningococcal B vaccine (4CMenB) in children and adolescents: a systematic review and meta-analysis. (2018) (44)
Discussion: Why "An estimate of the science-wise false discovery rate and application to the top medical literature" is false. (2014) (44)
Ethics and Epistemology in Big Data Research (2017) (44)
Erratum: Power failure: Why small sample size undermines the reliability of neuroscience (Nature Reviews Neuroscience (2013) 14 (365-376)) (2013) (44)
Genome-wide association screens for Achilles tendon and ACL tears and tendinopathy (2017) (44)
STrengthening the Reporting of OBservational studies in Epidemiology — Molecular Epidemiology STROBE-ME: an extension of the STROBE statement [J Clin Epidemiol 2011;64(12):1350–1363] (2012) (44)
Shared epitopes and rheumatoid arthritis: disease associations in Greece and meta-analysis of Mediterranean European populations. (2002) (44)
Reporting of Human Genome Epidemiology (HuGE) association studies: An empirical assessment (2008) (43)
The Complexities of Evaluating the Exposome in Psychiatry: A Data-Driven Illustration of Challenges and Some Propositions for Amendments (2018) (43)
The worldwide clinical trial research response to the COVID-19 pandemic - the first 100 days. (2020) (43)
Evaluation of the potential excess of statistically significant findings in published genetic association studies: application to Alzheimer's disease. (2008) (43)
Primary study authors of significant studies are more likely to believe that a strong association exists in a heterogeneous meta-analysis compared with methodologists. (2012) (43)
EULAR points to consider for conducting clinical trials in systemic lupus erythematosus (2008) (43)
Gene–environment interactions and colorectal cancer risk: An umbrella review of systematic reviews and meta‐analyses of observational studies (2019) (43)
Differentiating Biases from Genuine Heterogeneity: Distinguishing Artifactual from Substantive Effects (2006) (42)
Impact of a Genetic Risk Score for Coronary Artery Disease on Reducing Cardiovascular Risk: A Pilot Randomized Controlled Study (2017) (42)
Selective Cutoff Reporting in Studies of Diagnostic Test Accuracy: A Comparison of Conventional and Individual-Patient-Data Meta-Analyses of the Patient Health Questionnaire-9 Depression Screening Tool (2017) (42)
Academic medicine: the evidence base (2004) (42)
Prevention and Management of Non-Communicable Disease: The IOC Consensus Statement, Lausanne 2013 (2013) (42)
Predictors and impact of patients lost to follow-up in a long-term randomized trial of immediate versus deferred antiretroviral treatment. (1997) (41)
The rapid, massive growth of COVID-19 authors in the scientific literature (2020) (41)
Clinical trials in sub-Saharan Africa and established standards of care: a systematic review of HIV, tuberculosis, and malaria trials. (2004) (41)
Are mortality differences detected by administrative data reliable and actionable? (2013) (41)
Effect of early patient enrollment on the time to completion and publication of randomized controlled trials. (2001) (41)
Assessment of gene‐by‐sex interaction effect on bone mineral density (2012) (41)
Neglected tropical diseases: survey and geometry of randomised evidence (2012) (41)
Bayes factors for superiority, non-inferiority, and equivalence designs (2019) (41)
Registration practices for observational studies on ClinicalTrials.gov indicated low adherence. (2016) (40)
We need more randomized trials in nutrition-preferably large, long-term, and with negative results. (2016) (40)
Unscientific beliefs about scientific topics in nutrition. (2014) (40)
Predictive value of viral load measurements in asymptomatic untreated HIV‐1 infection: a mathematical model (1996) (40)
Toward unrestricted use of public genomic data (2019) (40)
Interpretation of epidemiologic studies very often lacked adequate consideration of confounding. (2018) (40)
Radiofrequency Ablation Versus Antiarrhythmic Drug Therapy for Atrial Fibrillation: Meta-Analysis of Quality of Life, Morbidity, and Mortality. (2016) (40)
Diagnostic accuracy of the Edinburgh Postnatal Depression Scale (EPDS) for detecting major depression in pregnant and postnatal women: protocol for a systematic review and individual patient data meta-analyses (2015) (40)
Suitable monitoring approaches to antiretroviral therapy in resource-poor settings: setting the research agenda. (2003) (40)
Statins and Multiple Noncardiovascular Outcomes (2018) (40)
The HuGENetTM HuGE Review Handbook, version 1.0 (2006) (39)
Populating the Data Ark: An attempt to retrieve, preserve, and liberate data from the most highly-cited psychology and psychiatry articles (2018) (39)
Mega-trials for blockbusters. (2013) (39)
Replication, Duplication, and Waste in a Quarter Million Systematic Reviews and Meta-Analyses. (2018) (39)
Kinetics of antibody concentration and avidity for the assessment of immune response to pneumococcal vaccine among children with bone marrow transplants. (2000) (39)
Population‐specific frequencies for LRRK2 susceptibility variants in the genetic epidemiology of Parkinson's disease (GEO‐PD) consortium (2013) (39)
Large trials vs meta-analysis of smaller trials. How do their results compare? (1997) (39)
Distinguishing true from false positives in genomic studies: p values (2013) (39)
Evidence from crossover trials: empirical evaluation and comparison against parallel arm trials. (2007) (39)
Common genetic variants for breast cancer: 32 largely refuted candidates and larger prospects. (2006) (39)
Very large treatment effects in randomised trials as an empirical marker to indicate whether subsequent trials are necessary: meta-epidemiological assessment (2016) (39)
Mortality in persons with mental disorders is substantially overestimated using inpatient psychiatric diagnoses. (2013) (39)
Erratum: UCHL1 is a Parkinson's disease susceptibility gene (Annals of Neurology (April 2004) 55 (512-521)) (2004) (38)
Perceived information gain from randomized trials correlates with publication in high-impact factor journals. (2012) (38)
Identification and evaluation of risk of generalizability biases in pilot versus efficacy/effectiveness trials: a systematic review and meta-analysis (2020) (38)
Use of E-values for addressing confounding in observational studies-an empirical assessment of the literature. (2020) (38)
Replication and Predictive Value of SNPs Associated with Melanoma and Pigmentation Traits in a Southern European Case-Control Study (2013) (38)
Association Between Pediatric Clinical Trials and Global Burden of Disease (2014) (38)
High quality of the evidence for medical and other health-related interventions was uncommon in Cochrane systematic reviews. (2016) (38)
A list of highly influential biomedical researchers, 1996–2011 (2013) (37)
Over- and under-estimation of COVID-19 deaths (2021) (37)
Visualizing the invisible: The effect of asymptomatic transmission on the outbreak dynamics of COVID-19 (2020) (37)
Evaluation of Association of HNF1B Variants with Diverse Cancers: Collaborative Analysis of Data from 19 Genome-Wide Association Studies (2010) (37)
Allergens responsible for allergic contact dermatitis among children: a systematic review and meta‐analysis (2011) (37)
Effects of different chemotherapy regimens on survival for advanced cervical cancer: systematic review and meta-analysis. (2007) (37)
Updated field synopsis and systematic meta-analyses of genetic association studies in cutaneous melanoma: the MelGene database. (2015) (37)
Collaborative Analysis of (cid:1) -Synuclein Gene Promoter Variability and Parkinson Disease (2006) (37)
Strengthening the reporting of genetic risk prediction studies: the GRIPS statement. (2011) (37)
Systematic assessment of the correlations of household income with infectious, biochemical, physiological, and environmental factors in the United States, 1999-2006. (2015) (36)
Inferior vena cava filters and postoperative outcomes in patients undergoing bariatric surgery: a meta-analysis. (2014) (36)
Recurrent pregnancy loss and autoantibody profile in autoimmune diseases. (1999) (36)
To replicate or not to replicate: the case of pharmacogenetic studies: Have pharmacogenomics failed, or do they just need larger-scale evidence and more replication? (2013) (36)
EULAR points to consider for conducting clinical trials in systemic lupus erythematosus: literature based evidence for the selection of endpoints (2008) (36)
Evaluation of Data Sharing After Implementation of the International Committee of Medical Journal Editors Data Sharing Statement Requirement (2021) (36)
Effect estimates of COVID-19 non-pharmaceutical interventions are non-robust and highly model-dependent (2021) (36)
Nested Randomized Trials in Large Cohorts and Biobanks: Studying the Health Effects of Lifestyle Factors (2008) (36)
How significant is sensorineural hearing loss in primary Sjögren's syndrome? An individually matched case-control study. (2001) (36)
Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials (2021) (36)
Bayesian meta‐analysis and meta‐regression for gene–disease associations and deviations from Hardy–Weinberg equilibrium (2007) (36)
Opportunities and Challenges for Selected Emerging Technologies in Cancer Epidemiology: Mitochondrial, Epigenomic, Metabolomic, and Telomerase Profiling (2012) (36)
Increasing efficiency of preclinical research by group sequential designs (2017) (35)
Hijacked evidence-based medicine: stay the course and throw the pirates overboard. (2017) (35)
Clinical Genomics: From Pathogenicity Claims to Quantitative Risk Estimates. (2016) (35)
Comparison of large versus smaller randomized trials for mental health-related interventions. (2005) (35)
Statistical issues for HIV surrogate endpoints: point/counterpoint. An NIAID workshop. (1998) (35)
Concordance of Sleep and Pain Outcomes of Diverse Interventions: An Umbrella Review (2012) (35)
Meta-analysis of the association between low-affinityFcγ receptor gene polymorphisms and hematologic and autoimmune diseases (2001) (34)
Generating comparative evidence on new drugs and devices after approval (2020) (34)
A roadmap for successful applications of clinical proteomics (2011) (34)
Randomized Trial of Personal Genomics for Preventive Cardiology: Design and Challenges (2012) (34)
Clinical Trial Evidence Supporting US Food and Drug Administration Approval of Novel Cancer Therapies Between 2000 and 2016 (2020) (34)
B-Cell epitope mapping of DNA topoisomerase I defines epitopes strongly associated with pulmonary fibrosis in systemic sclerosis. (2000) (34)
Expectations and challenges stemming from genome-wide association studies. (2008) (34)
Optimal type I and type II error pairs when the available sample size is fixed. (2013) (34)
When to replicate systematic reviews of interventions: consensus checklist (2020) (34)
A genome-wide copy number association study of osteoporotic fractures points to the 6p25.1 locus (2013) (34)
Sources of funding for Nobel Prize‐winning work: public or private? (2010) (34)
The protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants (2014) (34)
Epidemiologic design and analysis for proteomic studies: a primer on -omic technologies. (2015) (33)
Comparison of major depression diagnostic classification probability using the SCID, CIDI, and MINI diagnostic interviews among women in pregnancy or postpartum: An individual participant data meta‐analysis (2019) (33)
Protect us from poor-quality medical research. (2018) (33)
Long-term productive human immunodeficiency virus-1 infection in human infant microglia. (1995) (33)
Heterogeneity-based genome search meta-analysis for preeclampsia (2006) (33)
Assessment of cumulative evidence for the association between glutathione S-transferase polymorphisms and lung cancer: application of the Venice interim guidelines (2010) (32)
Comparative effectiveness of medical interventions in adults versus children. (2010) (32)
Sjögren's syndrome: too many associations, too limited evidence. The enigmatic example of CNS involvement. (1999) (32)
Genetic Predisposition to Asthma and Atopy (2005) (31)
Using lifetime risk estimates in personal genomic profiles: estimation of uncertainty. (2009) (31)
Retiring statistical significance would give bias a free pass (2019) (31)
Susceptibility variants for rheumatoid arthritis in the TRAF1-C5 and 6q23 loci: a meta-analysis (2009) (31)
Trends in Citations to Books on Epidemiological and Statistical Methods in the Biomedical Literature (2013) (31)
Calculating additive treatment effects from multiple randomized trials provides useful estimates of combination therapies. (2012) (31)
Improving the integrity of published science: An expanded taxonomy of retractions and corrections (2018) (30)
Overlapping network meta-analyses on the same topic: survey of published studies. (2017) (30)
Calibration of credibility of agnostic genome‐wide associations (2008) (30)
Improving the drug development process: more not less randomized trials. (2014) (30)
Are randomized trials obsolete or more important than ever in the genomic era? (2013) (30)
The Obesity Paradox: A Misleading Term That Should Be Abandoned (2018) (30)
Strengthening the Reporting of Genetic Risk Prediction Studies: The GRIPS Statement (2011) (30)
Magnitude of effects in clinical trials published in high-impact general medical journals. (2011) (30)
Meta-analyses Can Be Credible and Useful: A New Standard (2017) (30)
Guidelines for Translational Research in Heart Failure (2015) (30)
Role of sepiapterin reductase gene at the PARK3 locus in Parkinson's disease (2011) (30)
Impact of epidemic and individual heterogeneity on the population distribution of disease progression rates. An example from patient populations in trials of human immunodeficiency virus infection. (1996) (30)
Risk factors and risk prediction models for colorectal cancer metastasis and recurrence: an umbrella review of systematic reviews and meta-analyses of observational studies (2020) (30)
Visualizing the invisible: The effect of asymptomatic transmission on the outbreak dynamics of COVID-19 (2020) (29)
Maternal viral load and the risk of perinatal transmission of HIV-1. (1999) (29)
P values in display items are ubiquitous and almost invariably significant: A survey of top science journals (2018) (29)
Homophily and co-occurrence patterns shape randomized trials agendas: illustration in antifungal agents. (2011) (29)
Susceptibility of SARS-CoV-2 Omicron Variants to Therapeutic Monoclonal Antibodies: Systematic Review and Meta-analysis (2022) (29)
Population-wide generalizability of genome-wide discovered associations. (2009) (29)
PREDIMED trial of Mediterranean diet: retracted, republished, still trusted? (2019) (29)
The role of FcgammaRIIA and IIIA polymorphisms in autoimmune diseases. (2004) (29)
Potential increased risk of cancer from commonly used medications: an umbrella review of meta-analyses. (2014) (29)
Genetic and molecular epidemiology (2007) (28)
Completeness of main outcomes across randomized trials in entire discipline: survey of chronic lung disease outcomes in preterm infants (2015) (28)
Determinants of patient recruitment in a multicenter clinical trials group: trends, seasonality and the effect of large studies (2001) (28)
Empirical Evaluation of Age Groups and Age-Subgroup Analyses in Pediatric Randomized Trials and Pediatric Meta-analyses (2012) (28)
NIAID Workshop, Memphis, Tennessee, 25-26 March 1997: Statistical issues for HIV surrogate endpoints: Point/counterpoint (1998) (28)
This I believe in genetics: discovery can be a nuisance, replication is science, implementation matters (2013) (28)
Design, quality, and bias in randomized controlled trials of systemic lupus erythematosus. (2003) (28)
DIETFITS study (diet intervention examining the factors interacting with treatment success) - Study design and methods. (2017) (28)
Laboratory Mouse Models for the Human Genome-Wide Associations (2010) (28)
The credibility crisis in research: Can economics tools help? (2017) (27)
Prediction of Melanoma Risk in a Southern European Population Based on a Weighted Genetic Risk Score. (2016) (27)
Systematic assessment of pharmaceutical prescriptions in association with cancer risk: a method to conduct a population-wide medication-wide longitudinal study (2016) (27)
Correction: Empirical assessment of published effect sizes and power in the recent cognitive neuroscience and psychology literature (2016) (27)
Probability of major depression diagnostic classification based on the SCID, CIDI and MINI diagnostic interviews controlling for Hospital Anxiety and Depression Scale - Depression subscale scores: An individual participant data meta-analysis of 73 primary studies. (2019) (27)
Who is afraid of reviewers’ comments? Or, why anything can be published and anything can be cited (2010) (27)
Citation of randomized evidence in support of guidelines of therapeutic and preventive interventions. (2002) (27)
The Gini coefficient as a measure for understanding accrual inequalities in multicenter clinical studies. (2004) (27)
The elderly were under-represented in osteoarthritis clinical trials. (2009) (27)
Risk and protective factors for anxiety and obsessive-compulsive disorders: an umbrella review of systematic reviews and meta-analyses (2019) (27)
Non‐replication of association for six polymorphisms from meta‐analysis of genome‐wide association studies of Parkinson's disease: Large‐scale collaborative study (2009) (27)
Preprint Servers' Policies, Submission Requirements, and Transparency in Reporting and Research Integrity Recommendations. (2020) (27)
RESPONSE: Re: Neoadjuvant Versus Adjuvant Systemic Treatment in Breast Cancer: A Meta-Analysis (2005) (27)
Diagnostic accuracy of the Geriatric Depression Scale-30, Geriatric Depression Scale-15, Geriatric Depression Scale-5 and Geriatric Depression Scale-4 for detecting major depression: protocol for a systematic review and individual participant data meta-analysis (2018) (27)
Stealth research: Lack of peer‐reviewed evidence from healthcare unicorns (2019) (27)
Molecular Bias (2005) (27)
Discontinuation of Pneumocystis carinii prophylaxis in patients infected with human immunodeficiency virus: a meta-analysis and decision analysis. (2001) (27)
Randomized Trials of Neurosurgical Interventions: A Systematic Appraisal (2004) (27)
Heterogeneous views on heterogeneity. (2009) (27)
Flawed methods and inappropriate conclusions for health policy on overweight and obesity: the Global BMI Mortality Collaboration meta‐analysis (2019) (27)
Why replication has more scientific value than original discovery (2018) (26)
Field-wide meta-analyses of observational associations can map selective availability of risk factors and the impact of model specifications. (2016) (26)
Limits to forecasting in personalized medicine: An overview (2009) (26)
Randomized trials are frequently fragmented in multiple secondary publications. (2016) (26)
Corrigendum to "STrengthening the Reporting of OBservational studies in Epidemiology — Molecular Epidemiology (STROBE-ME): An extension of the STROBE statement" (Prev. Med. 53 (2011) 377-387) (2012) (26)
Recommendations and Practical Guidance for performing and reporting validation studies according to the Universal Standard for the validation of blood pressure measuring devices by the Association for the Advancement of Medical Instrumentation/European Society of Hypertension/International Organizat (2020) (26)
Prevention and control of neglected tropical diseases: overview of randomized trials, systematic reviews and meta-analyses. (2014) (26)
Association of RGS4 variants with schizotypy and cognitive endophenotypes at the population level (2008) (26)
Change in age distribution of COVID-19 deaths with the introduction of COVID-19 vaccination (2021) (25)
Diagnostic accuracy of the Depression subscale of the Hospital Anxiety and Depression Scale (HADS-D) for detecting major depression: protocol for a systematic review and individual patient data meta-analyses (2016) (25)
Precision shielding for COVID-19: metrics of assessment and feasibility of deployment (2020) (25)
Industry involvement and baseline assumptions of cost-effectiveness analyses: diagnostic accuracy of the Papanicolaou test (2011) (25)
Randomised trials comparing chemotherapy regimens for advanced non-small cell lung cancer: biases and evolution over time. (2003) (25)
Coronavirus disease 2019: the harms of exaggerated information and non-evidence-based measures. (2020) (25)
Application of credibility ceilings probes the robustness of meta-analyses of biomarkers and cancer risk. (2015) (25)
Dynamics of HIV-1 viral load rebound among patients with previous suppression of viral replication (2000) (25)
COVID‐19 vaccination in children and university students (2021) (25)
Concordance of functional in vitro data and epidemiological associations in complex disease genetics (2006) (25)
Neglecting Major Health Problems and Broadcasting Minor, Uncertain Issues in Lifestyle Science. (2019) (24)
Clinicopathologic predictors of death and ESRD in patients with pauci-immune necrotizing glomerulonephritis. (2003) (24)
Use of neural networks to model complex immunogenetic associations of disease: human leukocyte antigen impact on the progression of human immunodeficiency virus infection. (1998) (24)
Academic criteria for appointment, promotion and rewards in medical research: where's the evidence? (2016) (24)
Osteomyelitis: antigranulocyte scintigraphy with 99mTC radiolabeled monoclonal antibodies for diagnosis-- meta-analysis. (2007) (24)
Modern health care as a game theory problem (2015) (24)
Randomized controlled trials: Often flawed, mostly useless, clearly indispensable: A commentary on Deaton and Cartwright. (2018) (24)
Effects of non-pharmaceutical interventions on COVID-19: A Tale of Two Models (2020) (24)
Larger effect sizes in nonrandomized studies are associated with higher rates of EMA licensing approval. (2018) (24)
The Reproducibility Wars: Successful, Unsuccessful, Uninterpretable, Exact, Conceptual, Triangulated, Contested Replication. (2017) (24)
Effect of CCR5-Δ32 heterozygosity on the risk of perinatal HIV-1 infection: A meta-analysis (2003) (24)
The role of meta-analyses and umbrella reviews in assessing the harms of psychotropic medications: beyond qualitative synthesis (2018) (24)
Evidence-based medicine and big genomic data. (2018) (24)
Meta-analyses identify differentially expressed microRNAs in Parkinson’s disease (2018) (24)
Partisan Perspectives in the Medical Literature: A Study of High Frequency Editorialists Favoring Hormone Replacement Therapy (2010) (23)
Assessment of Pragmatism in Recently Published Randomized Clinical Trials (2018) (23)
Most meta-analyses of drug interventions have narrow scopes and many focus on specific agents. (2013) (23)
Some main problems eroding the credibility and relevance of randomized trials. (2008) (23)
A Comprehensive Analysis of Protocols for Deriving Dopaminergic Neurons from Human Pluripotent Stem Cells (2018) (23)
Network geometry shows evidence sequestration for medical vs. surgical practices: treatments for basal cell carcinoma. (2014) (23)
Turning the pump handle: evolving methods for integrating the evidence on gene-disease association. (2007) (23)
F-Fluorodeoxyglucose Positron Emission Tomography to Evaluate Cervical Node Metastases in Patients With Head and Neck Squamous Cell Carcinoma : A Meta-analysis (2008) (23)
Challenges and Lessons Learned From COVID-19 Trials: Should We Be Doing Clinical Trials Differently? (2021) (23)
Effects of platelet glycoprotein IIb/IIIa receptor blockers in non-ST segment elevation acute coronary syndromes: benefit and harm in different age subgroups (2006) (23)
Toward a paradigm shift in treatment and research of mental disorders (2019) (23)
Vibration of effects from diverse inclusion/exclusion criteria and analytical choices: 9216 different ways to perform an indirect comparison meta-analysis (2019) (23)
Excess significance bias in repetitive transcranial magnetic stimulation literature for neuropsychiatric disorders (2019) (23)
Arabian nights—1001 tales of how pharmaceutical companies cater to the material needs of doctors: case report (2000) (23)
Risk and severity of SARS-CoV-2 reinfections during 2020–2022 in Vojvodina, Serbia: A population-level observational study (2022) (23)
Safety of Medical Interventions in Children Versus Adults (2014) (22)
A systematic evaluation of 151 candidate genes for their association with osteoporosis and osteoporotic fracture in a meta-analysis of genome-wide association data (2009) (22)
Estimating the contribution of genetic variants to difference in incidence of disease between population groups (2012) (22)
Doctors’ versus patients’ global assessments of treatment effectiveness: empirical survey of diverse treatments in clinical trials (2008) (22)
Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration (2011) (22)
What is wrong with clinical proteomics? (2014) (22)
Susceptibility to HIV infection--disentangling host genetics and host behavior. (2006) (22)
Independent discussion sections for improving inferential reproducibility in published research (2019) (22)
Risk of myelotoxicity with intravenous cyclophosphamide in patients with systemic lupus erythematosus. (2002) (22)
Uncontrolled pearls, controlled evidence, meta-analysis and the individual patient. (1998) (22)
Antiretroviral therapy for initial human immunodeficiency virus/AIDS treatment: critical appraisal of the evidence from over 100 randomized trials and 400 systematic reviews and meta-analyses. (2014) (22)
Important Drug Safety Information on the Internet (2003) (22)
How to Use a Subgroup Analysis (2014) (22)
Antidepressants might work for people with major depression: where do we go from here? (2018) (21)
How many contemporary medical practices are worse than doing nothing or doing less? (2013) (21)
Development of a combined database for meta‐epidemiological research (2010) (21)
Design and Challenges (2012) (21)
Treatment effects in randomised trials using routinely collected data for outcome assessment versus traditional trials: meta-research study (2021) (21)
Genome-wide association study identifies a locus associated with rotator cuff injury (2017) (21)
Neurosurgical Randomized Controlled Trials—Distance Travelled (2018) (21)
Evaluation of confounding in epidemiologic studies assessing alcohol consumption on the risk of ischemic heart disease (2019) (21)
Data Sharing Under the General Data Protection Regulation (2021) (21)
Benefit of COVID-19 vaccination accounting for potential risk compensation (2021) (21)
Stealth Research and Theranos: Reflections and Update 1 Year Later. (2016) (21)
The end of the COVID‐19 pandemic (2022) (21)
Massive covidization of research citations and the citation elite (2022) (21)
Comparison of pandemic excess mortality in 2020–2021 across different empirical calculations (2022) (21)
The importance of transparency and reproducibility in artificial intelligence research (2020) (20)
Infection fatality rate of COVID-19 in community-dwelling elderly populations (2022) (20)
Commentary: Adjusting for bias: a user's guide to performing plastic surgery on meta-analyses of observational studies. (2011) (20)
Different Black Box Warning Labeling for Same-Class Drugs (2011) (20)
Erratum to: STrengthening the reporting of OBservational studies in Epidemiology—Molecular Epidemiology (STROBE-ME): an extension of the STROBE statement (2012) (20)
Use and reporting of Bland–Altman analyses in studies of self-reported versus measured weight and height (2019) (20)
Current use of routinely collected health data to complement randomized controlled trials: a meta-epidemiological survey. (2016) (20)
Sex-specific differences in effect size estimates at established complex trait loci (2012) (20)
International collaboration, funding and association with burden of disease in randomized controlled trials in Africa. (2005) (20)
Machine learning and AI research for Patient Benefit: 20 Critical Questions on Transparency, Replicability, Ethics and Effectiveness (2018) (20)
Genome-wide Association Study for Radiographic Vertebral Fractures: A Potential Role for the 16q24 BMD Locus versus Lessons Learned from Challenging Phenotype Definition. (2014) (20)
Prevalence and Characteristics of Interventional Trials Conducted Exclusively in Elderly Persons: A Cross-Sectional Analysis of Registered Clinical Trials (2016) (20)
WASTE HEAT RECOVERY FROM DIESEL ENGINES (1984) (20)
The use of older studies in meta-analyses of medical interventions: a survey (2009) (20)
Prevention and management of noncommunicable disease: the IOC Consensus Statement, Lausanne 2013. (2013) (19)
Meta-analysis of randomized controlled trials on the comparative efficacy and safety of azithromycin against other antibiotics for lower respiratory tract infections. (2001) (19)
Molecular evidence‐based medicine (2007) (19)
Global assessment of C-reactive protein and health-related outcomes: an umbrella review of evidence from observational studies and Mendelian randomization studies (2020) (19)
STrengthening the Reporting of OBservational studies in Epidemiology: Molecular Epidemiology STROBE-ME. An extension of the STROBE statement (2011) (19)
Improving Disclosure of Financial Conflicts of Interest for Research on Psychosocial Interventions (2018) (19)
Knowledge Integration in Cancer: Current Landscape and Future Prospects (2012) (19)
STrengthening the REporting of Genetic Association studies (STREGA): an extension of the STROBE Statement. (2009) (19)
Network meta-analyses performed by contracting companies and commissioned by industry (2016) (18)
Is there a glass ceiling for highly cited scientists at the top of research universities? (2010) (18)
Dental Research Waste in Design, Analysis, and Reporting: A Scoping Review (2020) (18)
Media and social media attention to retracted articles according to Altmetric (2021) (18)
Probability of Major Depression Classification Based on the SCID, CIDI, and MINI Diagnostic Interviews: A Synthesis of Three Individual Participant Data Meta-Analyses (2020) (18)
Failure to Replicate: Sound the Alarm (2015) (18)
Association of GSTM 1 , GSTT 1 , and GSTP 1 Gene Polymorphisms with the Risk of Prostate Cancer : A Meta-analysis (2005) (18)
STrengthening the Reporting of OBservational studies in Epidemiology--Molecular Epidemiology STROBE-ME: an extension of the STROBE statement. (2011) (18)
Large-scale Meta-analysis of Genome-wide Association (GWA) Scans for Osteoporosis Traits: the GEFOS Consortium (2008) (18)
Persistent reservations against contradicted percutaneous coronary intervention indications: citation content analysis. (2009) (18)
Meta-analysis in public health: potentials and problems (2006) (18)
Depression prevalence based on the Edinburgh Postnatal Depression Scale compared to Structured Clinical Interview for DSM DIsorders classification: Systematic review and individual participant data meta‐analysis (2020) (18)
18 F-FDG PET for Evaluation of Bone Marrow Infiltration in Staging of Lymphoma: (2005) (18)
Time to abandon early detection cancer screening (2019) (18)
Is vitamin C superior to diltiazem for radial artery vasodilation in patients awaiting coronary artery bypass grafting? (2003) (18)
Selective discussion and transparency in microarray research findings for cancer outcomes. (2007) (17)
Geometry of the randomized evidence for treatments of pulmonary hypertension. (2013) (17)
Strengthening the reporting of genetic risk prediction studies: the GRIPS statement (2011) (17)
Design and quality considerations for randomized controlled trials in systemic sclerosis. (2002) (17)
A simulation study of the strength of evidence in the recommendation of medications based on two trials with statistically significant results (2017) (17)
Determinants of economic growth: Different time different answer? (2020) (17)
A meta-analysis but not a systematic review: an evaluation of the Global BMI Mortality Collaboration. (2017) (17)
Publication Delay of Randomized Trials on 2009 Influenza A (H1N1) Vaccination (2011) (17)
Impact of phenotype definition on genome-wide association signals: empirical evaluation in human immunodeficiency virus type 1 infection. (2011) (17)
Factors influencing estimated effectiveness of COVID-19 vaccines in non-randomised studies (2022) (17)
Biomedical Journals and Preprint Services: Friends or Foes? (2017) (17)
Hardy–Weinberg Equilibrium (2008) (17)
Registering diagnostic and prognostic trials of tests: is it the right thing to do? (2014) (17)
Lost Evidence From Registered Large Long-Unpublished Randomized Controlled Trials: A Survey (2019) (17)
Medical journal requirements for clinical trial data sharing: Ripe for improvement (2021) (17)
Is It Possible to Recognize a Major Scientific Discovery? (2015) (16)
Limitations of medical research and evidence at the patient-clinician encounter scale. (2013) (16)
All science should inform policy and regulation (2018) (16)
Meta-analysis identifies loci affecting levels of the potential osteoarthritis biomarkers sCOMP and uCTX-II with genome wide significance (2014) (16)
Empirical evidence for low reproducibility indicates low pre-study odds (2013) (16)
Detecting publication selection bias through excess statistical significance (2021) (16)
Single pivotal trials with few corroborating characteristics were used for FDA approval of cancer therapies. (2019) (16)
Preserving equipoise and performing randomised trials for COVID-19 social distancing interventions (2020) (16)
Anticipating consequences of sharing raw data and code and of awarding badges for sharing. (2016) (16)
Reporting of demographic data and representativeness in machine learning models using electronic health records (2020) (16)
Ala45Thr polymorphism of the NEUROD1 gene and diabetes susceptibility: a meta-analysis (2005) (16)
Industry-funded versus non-profit-funded critical care research: a meta-epidemiological overview (2018) (15)
Hundreds of thousands of zombie randomised trials circulate among us (2020) (15)
Effect of left ventricular ejection fraction and QRS duration on the survival benefit of implantable cardioverter-defibrillators: meta-analysis of primary prevention trials. (2013) (15)
Most psychotherapies do not really work, but those that might work should be assessed in biased studies (2016) (15)
Access to data from clinical trials in the COVID-19 crisis: open, flexible, and time-sensitive (2020) (15)
Two Genetic Variants Associated with Plantar Fascial Disorders (2018) (15)
Isolated intraparotid Kaposi sarcoma in human immunodeficiency virus type 1 infection. (2003) (15)
A test for reporting bias in trial networks: simulation and case studies (2014) (15)
Recent Randomized Controlled Trials in Otolaryngology (2015) (15)
Shortening self‐report mental health symptom measures through optimal test assembly methods: Development and validation of the Patient Health Questionnaire‐Depression‐4 (2018) (15)
Self-Reported Health in High and Very High Incomes (2006) (15)
Why Cochrane should prioritise sharing data (2018) (15)
Collaborative Cancer Epidemiology in the 21st Century: The Model of Cancer Consortia (2013) (14)
How often can meta-analyses of individual-level data individualize treatment? A meta-epidemiologic study. (2018) (14)
Analysis of life‐long strategies to prevent Pneumocystis carinii pneumonia in patients with variable HIV progression rates (1998) (14)
Genome-wide association study for radiographic vertebral fractures: a potential role for the 16q24 BMD locus. (2014) (14)
Randomized evidence on chemotherapy and hormonal therapy regimens for advanced endometrial cancer: an overview of survival data. (2006) (14)
Meta-analysis of the association between low-affinity Fcgamma receptor gene polymorphisms and hematologic and autoimmune disease. (2001) (14)
True and false positive rates for different criteria of evaluating statistical evidence from clinical trials (2018) (14)
Pneumococcal aortitis in the antibiotic era. (1995) (14)
Consideration of confounding was suboptimal in the reporting of observational studies in psychiatry: a meta-epidemiological study. (2019) (14)
The role of outdoor and indoor air quality in the spread of SARS-CoV-2: Overview and recommendations by the research group on COVID-19 and particulate matter (RESCOP commission) (2022) (14)
Online randomized controlled experiments at scale: lessons and extensions to medicine (2020) (14)
HLA associations of anti-beta2 glycoprotein I response in a Greek cohort with antiphospholipid syndrome and meta-analysis of four ethnic groups. (1999) (14)
The Ninth International Congress on Peer Review and Scientific Publication: A Call for Research. (2019) (13)
Impact of vaccine herd-protection effects in cost-effectiveness analyses of childhood vaccinations. A quantitative comparative analysis (2017) (13)
Systematic identification of correlates of HIV infection: an X-wide association study (2018) (13)
Comparison of viral load and human leukocyte antigen statistical and neural network predictive models for the rate of HIV-1 disease progression across two cohorts of homosexual men. (1999) (13)
An empirical comparison of meta-analyses of published gene-disease associations versus consortium analyses (2009) (13)
Association of the CYP 17 Gene Polymorphism with the Risk of Prostate Cancer : A Meta-Analysis (2003) (13)
Depression prevalence using the HADS-D compared to SCID major depression classification: An individual participant data meta-analysis. (2020) (13)
Claims for improved survival from systemic corticosteroids in diverse conditions: an umbrella review (2012) (13)
Evaluation of the association of autoantibodies with mortality in the very elderly: a cohort study. (2003) (13)
Non-inferiority versus superiority trial design for new antibiotics in an era of high antimicrobial resistance: the case for post-marketing, adaptive randomised controlled trials. (2019) (13)
Two genetic loci associated with ankle injury (2017) (13)
Reporting of Systematic Reviews: The Challenge of Genetic Association Studies (2007) (12)
Publishing research with P-values: Prescribe more stringent statistical significance or proscribe statistical significance? (2019) (12)
Precision medicine for individual patients should use population group averages and larger, not smaller, groups (2018) (12)
HIV Lipodystrophy Case Definition using Artificial Neural Network Modelling (2002) (12)
Off-label treatments were not consistently better or worse than approved drug treatments in randomized trials. (2018) (12)
Validation protocols for blood pressure measuring devices: the impact of the European Society of Hypertension International Protocol and the development of a Universal Standard. (2019) (12)
US Food and Drug Administration Approvals of Drugs and Devices Based on Nonrandomized Clinical Trials (2019) (12)
Signals Among Signals: Prioritizing Nongenetic Associations in Massive Data Sets (2019) (12)
Cochrane crisis: Secrecy, intolerance and evidence‐based values (2019) (12)
Hypnotic depth and postoperative death: a Bayesian perspective and an Independent Discussion of a clinical trial. (2019) (12)
A variational principle for underwater acoustic propagation in a three‐dimensional ocean environment (1990) (11)
Response to Therapy in Antiretroviral Therapy–Naive Patients With Isolated Nonnucleoside Reverse Transcriptase Inhibitor–Associated Transmitted Drug Resistance (2016) (11)
Recruitment and Results Reporting of COVID-19 Randomized Clinical Trials Registered in the First 100 Days of the Pandemic (2021) (11)
Late-starter sites in randomized controlled trials. (2003) (11)
Most healthcare interventions tested in Cochrane Reviews are not effective according to high quality evidence: a systematic review and meta-analysis. (2022) (11)
Levels of absolute survival benefit for systemic therapies of advanced cancer. a call for standards. (2003) (11)
On meta-analyses of meta-analyses (1996) (11)
Empirical assessment of bias in machine learning diagnostic test accuracy studies (2020) (11)
Research accomplishments that are too good to be true (2013) (11)
A Web-based database of genetic association studies in cutaneous melanoma enhanced with network-driven data exploration tools (2014) (11)
Citation metrics for appraising scientists: misuse, gaming and proper use (2020) (11)
Effect of CCR5-delta32 heterozygosity on the risk of perinatal HIV-1 infection: a meta-analysis. (2003) (11)
Invited commentary-Genetic prediction for common diseases. (2012) (11)
Commentary: Time to improve the reporting of harms in randomized controlled trials. (2021) (11)
Does the COVID-19 pandemic provide an opportunity to eliminate the tobacco industry? (2020) (11)
Unreformed nutritional epidemiology: a lamp post in the dark forest (2019) (11)
Noninferiority is almost certain with lenient noninferiority margins. (2016) (11)
Work honored by Nobel prizes clusters heavily in a few scientific fields (2020) (11)
Age-stratified infection fatality rate of COVID-19 in the non-elderly population (2022) (11)
Examining the robustness of observational associations to model, measurement and sampling uncertainty with the vibration of effects framework (2020) (11)
Fifty-Year Fate and Impact of General Medical Journals (2010) (11)
Citation Patterns Following a Strongly Contradictory Replication Result: Four Case Studies From Psychology (2021) (10)
PCI for stable coronary disease. (2007) (10)
Selection and Presentation of Imaging Figures in the Medical Literature (2010) (10)
Completeness of Safety Reporting in Randomized Trials (2017) (10)
Open letter to the leader of academic medicine (2007) (10)
Defending Biomedical Science in an Era of Threatened Funding. (2017) (10)
Inconsistent Guideline Recommendations for Cardiovascular Prevention and the Debate About Zeroing in on and Zeroing LDL-C Levels With PCSK9 Inhibitors. (2017) (10)
The quality of evidence for medical interventions does not improve or worsen: a Meta-Epidemiological Study of Cochrane Reviews. (2020) (10)
Bias in uncontrolled therapeutic trials in rheumatology due to selection of populations with extreme characteristics. (2001) (10)
Acute Sinusitis in Children (2003) (10)
Strengthening the reporting of Genetic Risk Prediction Studies: the GRIPS statement. (2011) (10)
Endgame: engaging the tobacco industry in its own elimination (2013) (10)
Editorial: Updated guidance on human genome epidemiology (HuGE) reviews and meta-analyses of genetic associations. (2014) (10)
Does evidence-based hearsay determine the use of medical treatments? (2017) (10)
Most recommended medical interventions reach P<0.005 for their primary outcomes in meta-analyses. (2019) (9)
An overview of recommendations and translational milestones for genomic tests in cancer (2014) (9)
OP0064 Joint EULAR/ERA-EDTA recommendations for the management of adult and pediatric lupus nephritis (2013) (9)
Emergence of large treatment effects from small trials--reply. (2013) (9)
Pharmacogenetics of the response to beta 2 agonist drugs: a systematic overview of the field. (2007) (9)
The Comparative Effectiveness of Innovative Treatments for Cancer (CEIT-Cancer) project: Rationale and design of the database and the collection of evidence available at approval of novel drugs (2018) (9)
Registered Randomized Trials Comparing Generic and Brand-Name Drugs: A Survey. (2016) (9)
Validity of observational evidence on putative risk and protective factors: appraisal of 3744 meta-analyses on 57 topics (2021) (9)
First-Trimester Ductus Venosus Screening for Cardiac Defects: A Meta-Analysis (2012) (9)
Author Correction: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials (2021) (9)
Petitions in scientific argumentation: Dissecting the request to retire statistical significance (2019) (9)
Appendicectomies in Albanians in Greece: outcomes in a highly mobile immigrant patient population (2001) (9)
Non-randomized studies using causal-modelling may give different answers than RCTs: a meta-epidemiological study. (2019) (9)
Gene expression profiling for individualized breast cancer chemotherapy: success or not? (2006) (9)
Risk of gastrointestinal bleeding from dexamethasone in children with bacterial meningitis (1994) (9)
Scientific reporting is suboptimal for aspects that characterize genetic risk prediction studies: a review of published articles based on the Genetic RIsk Prediction Studies statement. (2014) (9)
Examining the readiness of best evidence in medical education guides for integration into educational practice: A meta-synthesis (2018) (9)
The worldwide clinical trial research response to the COVID-19 pandemic - the first 100 days (2020) (9)
Relationship between event rates and treatment effects in clinical site differences within multicenter trials: an example from primary Pneumocystis carinii prophylaxis. (1999) (9)
When and how to replicate systematic reviews (2020) (9)
Therapy and prevention for mental health: What if mental diseases are mostly not brain disorders? (2019) (9)
Replication of genome-wide discovered breast cancer risk loci in the Cypriot population (2011) (9)
Research needs grants, funding and money – missing something? (2012) (9)
Strengthening the reporting of Genetic RIsk Prediction Studies: the GRIPS Statement. (2011) (9)
Data Mining Approaches to Reference Interval Studies. (2021) (9)
Twenty loci associated with bone mineral density identified by large-scale meta-analysis of genome-wide association datasets (2009) (8)
Scientific Communication Is Down at the Moment, Please Check Again Later (2012) (8)
Biases in obesity research: Identify, correct, endorse, or abandon effort? (2016) (8)
Mapping the expanded often inappropriate use of the Framingham Risk Score in the medical literature. (2014) (8)
Strengthening the reporting of genetic risk prediction studies: the GRIPS statement (2011) (8)
METHODS TO ENHANCE THE REPRODUCIBILITY OF PRECISION MEDICINE. (2016) (8)
METHODS TO ENSURE THE REPRODUCIBILITY OF BIOMEDICAL RESEARCH. (2017) (8)
Comparison of myocardial fractional flow reserve and intravascular ultrasound for the assessment of slotted‐tube stents (2001) (8)
Equivalency of the diagnostic accuracy of the PHQ-8 and PHQ-9: a systematic review and individual participant data meta-analysis – ERRATUM (2019) (8)
Vibration of effects in epidemiologic studies of alcohol consumption and breast cancer risk. (2020) (8)
Evaluating health system processes with randomized controlled trials. (2013) (8)
Correction: Evolution and Translation of Research Findings: From Bench to Where? (2007) (8)
Research: increasing value, reducing waste – Authors' reply (2014) (8)
Metformin and health outcomes: An umbrella review of systematic reviews with meta‐analyses (2021) (8)
Aspergillus fumigatus infection of a biloma. (1995) (8)
The rapid, massive infection of the scientific literature and authors by COVID-19 (2020) (8)
Re: Fruit and vegetable intake and overall cancer risk in the European Prospective Investigation into Cancer and Nutrition. (2011) (8)
NF-κB Modulates TNF-α Production by Alveolar Macrophages in Asymptomatic HIV-Seropositive Individuals1 (2000) (8)
Efficacy and acceptability of pharmacological and non-pharmacological interventions for non-specific chronic low back pain: a protocol for a systematic review and network meta-analysis (2020) (8)
Analysis of-Synuclein Gene Promoter Variability and Parkinson Disease (2006) (8)
An empirical comparison of three methods for multiple cutoff diagnostic test meta‐analysis of the Patient Health Questionnaire‐9 (PHQ‐9) depression screening tool using published data vs individual level data (2020) (8)
Appropriate vs clinically useful diagnostic tests. (2013) (7)
23-valent pneumococcal vaccination and HIV (2000) (7)
Evaluating and Strengthening the Evidence for Nutritional Bone Research: Ready to Break New Ground? (2020) (7)
Marginal structural models and other analyses allow multiple estimates of treatment effects in randomized clinical trials: Meta-epidemiological analysis. (2019) (7)
Most UK scientists who publish extremely highly-cited papers do not secure funding from major public and charity funders: A descriptive analysis (2019) (7)
Odds Are, It's Wrong - Science News (2010) (7)
Infection fatality rate of COVID-19 in community-dwelling populations with emphasis on the elderly: An overview (2021) (7)
The Decameron of poor research (2004) (7)
Awareness of the side effects of possessed medications in a community setting (2003) (7)
Vitamin D Receptor Gene Polymorphisms and Risk of Prostate Cancer (2003) (7)
Protein conjugate pneumococcal vaccines (2002) (7)
Reproducible pharmacokinetics (2019) (7)
Insomnia From Drug Treatments: Evidence From Meta‐analyses of Randomized Trials and Concordance With Prescribing Information (2017) (7)
Prevalence and significance of race and ethnicity subgroup analyses in Cochrane intervention reviews (2019) (7)
Does natural and hybrid immunity obviate the need for frequent vaccine boosters against SARS‐CoV‐2 in the endemic phase? (2022) (7)
Strengthening the reporting of genetic risk prediction studies: the GRIPS statement (2011) (7)
Benefit of COVID-19 vaccination accounting for potential risk compensation (2021) (7)
‘Stealth’ corporate innovation: an emerging threat for therapeutic drug development (2019) (7)
Pancreatitis Potentially Associated Drugs as a Risk Factor for Post–Endoscopic Retrograde Cholangiopancreatography Pancreatitis: A Prospective Cohort Study (2013) (7)
Translational research may be most successful when it fails. (2015) (7)
Burden of disease and randomized evidence in sub-Saharan Africa (2001) (7)
Comparative rates of harms in randomized trials from more developed versus less developed countries may be different. (2016) (7)
Massive citations to misleading methods and research tools: Matthew effect, quotation error and citation copying (2018) (7)
A meta-analysis of individual participant data constructed to align with prior expert views: comments on Bhupathiraju et al. (2017) (7)
Retrospective median power, false positive meta‐analysis and large‐scale replication (2021) (6)
Correction of phenotype misclassification based on high-discrimination genetic predictive risk models. (2012) (6)
Guidelines on Chemotherapy in Advanced Stage Gynecological Malignancies: An Evaluation of 224 Professional Societies and Organizations (2011) (6)
Effect of low-dose aspirin on health outcomes: An umbrella review of systematic reviews and meta-analyses. (2020) (6)
Lowering the P Value Threshold-Reply. (2018) (6)
Evidence generation and reproducibility in cell and gene therapy research: A call to action (2021) (6)
Inverse correlates of COVID-19 mortality across European countries during the first versus subsequent waves (2021) (6)
Reproducibility concerns (2012) (6)
Modelling of escalating outpatient antibiotic expenditures. (2003) (6)
Proceedings of the 4th World Conference on Research Integrity (2016) (6)
Cyclophosphamide in systemic sclerosis: light and shadows. (2004) (6)
Diagnosis of Sensorineural Hearing Loss with Neural Networks versus Logistic Regression Modeling of Distortion Product Otoacoustic Emissions (2004) (6)
Evaluation of a suggested novel method to adjust BMI calculated from self‐reported weight and height for measurement error (2021) (6)
A Genome-wide Association Study for Concussion Risk. (2020) (6)
A comparison of bivariate, multivariate random‐effects, and Poisson correlated gamma‐frailty models to meta‐analyze individual patient data of ordinal scale diagnostic tests (2017) (6)
Air pollution as cause of mental disease: Appraisal of the evidence (2019) (6)
Science, advocacy, and quackery in nutritional books: an analysis of conflicting advice and purported claims of nutritional best-sellers (2020) (6)
HIV: prevention of opportunistic infections. (2003) (6)
The value of meta-analysis in rheumatology research. (2004) (6)
Overall and COVID-19-specific citation impact of highly visible COVID-19 media experts: bibliometric analysis (2021) (6)
Cohort Profile: WELL living laboratory in China (WELL-China). (2021) (6)
Greece: Crisis, smoking and tobacco conflicts in social media (2017) (6)
Strengthening the Reporting of Genetic Risk Prediction Studies: The GRIPS Statement (2011) (6)
Options for publishing research without any P-values. (2019) (6)
Two Genetic Loci associated with Medial Collateral Ligament Injury (2017) (6)
Prediction of RECRUITment In randomized clinical Trials (RECRUIT-IT)—rationale and design for an international collaborative study (2020) (6)
Exact inference for disease prevalence based on a test with unknown specificity and sensitivity (2020) (6)
370 A GENOME-WIDE ASSOCIATION STUDY IDENTIFIES A LOCUS ON CHROMOSOME 7Q22 TO INFLUENCE SUSCEPTIBILITY FOR OSTEOARTHRITIS (2009) (6)
SRD 5 A 2 Gene Polymorphisms and the Risk of Prostate Cancer : A Meta-Analysis (2003) (6)
HIV: opportunistic infections. (2003) (6)
X-WAS, Traditional Epidemiology, and Policy Action (2011) (5)
Large scale evidence and replication: insights from rheumatology and beyond (2004) (5)
A vision for the European Journal of Clinical Investigation: note from the new editors (2010) (5)
NF-kappa B modulates TNF-alpha production by alveolar macrophages in asymptomatic HIV-seropositive individuals. (2000) (5)
Differential COVID-19 infection rates in children, adults, and elderly: Systematic review and meta-analysis of 38 pre-vaccination national seroprevalence studies (2023) (5)
Overestimation of Postpartum Depression Prevalence Based on a 5-item Version of the EPDS: Systematic Review and Individual Participant Data Meta-analysis (2020) (5)
Meta-Analysis of Therapeutic Trials (2018) (5)
Comparison of different scoring methods based on latent variable models of the PHQ-9: an individual participant data meta-analysis (2021) (5)
Reproducibility in the UK biobank of genome-wide significant signals discovered in earlier genome-wide association studies (2020) (5)
A vision for chronic disease prevention and intervention research: Report from a workshop (2014) (5)
Primary open angle glaucoma due to T377M MYOC: Population mapping of a Greek founder mutation in Northwestern Greece (2010) (5)
Environmental risk factors and interventions for obesity (2019) (5)
Age-treatment subgroup analyses in Cochrane intervention reviews: a meta-epidemiological study (2019) (5)
Handling the fragile vase of scientific practices. (2015) (5)
Citation of randomized evidence in support of guidelines of therapeutic and preventive interventions (2001) (5)
Management of Cancer Pain: Summary (2001) (5)
A proposed evaluation algorithm for the heterogeneity of the baseline risk within patient populations of clinical trial (1998) (5)
Family History–Wide Association Study to Identify Clinical and Environmental Risk Factors for Common Chronic Diseases (2019) (5)
Concordance of effects of medical interventions on hospital admission and readmission rates with effects on mortality (2013) (5)
Strengthening the reporting of genetic risk prediction studies: the GRIPS statement (2011) (5)
Constructive and obsessive criticism in science (2022) (5)
Reproducibility of real-world evidence studies using clinical practice data to inform regulatory and coverage decisions (2022) (5)
Systematic identification of interaction effects between validated genome- and environment-wide associations on Type 2 Diabetes Mellitus. (2013) (5)
Academic criteria for promotion and tenure in faculties of medicine: a cross-sectional study of the Canadian U15 universities (2021) (5)
Assessment of systematic effects of methodological characteristics on candidate genetic associations (2013) (5)
Association analyses of 47,500 individuals identifies six fracture loci and 82 BMD loci clustering in biological pathways that regulate osteoblast and osteoclast activity (2011) (5)
Response to letter by Forike et al.: more rigorous, not less, external validation is needed. (2016) (5)
Clinical trials: A transparent future for clinical trial reporting (2015) (5)
Non-randomised Ebola trials--lessons for optimal outbreak research. (2016) (4)
Human genome epidemiology: The road map revisited (2010) (4)
Contradictions in Highly Cited Clinical Research—Reply (2005) (4)
Reproducible research practices and transparency in reproductive endocrinology and infertility articles. (2020) (4)
Citation impact and social media visibility of Great Barrington and John Snow signatories for COVID-19 strategy (2022) (4)
Consent insufficient for data release—Response (2019) (4)
A meta-epidemiological assessment of transparency indicators of infectious disease models (2022) (4)
Insulin-dependent diabetes in AIDS. (1994) (4)
Redundant meta-analyses are common in genetic epidemiology. (2020) (4)
Ninth International Congress on Peer Review and Scientific Publication: Call for Abstracts. (2021) (4)
An umbrella review of effect size, bias, and power across meta‐analyses in emergency medicine (2021) (4)
Commentary: Salt and the assault of opinion on evidence. (2016) (4)
Strengthening the reporting of Genetic RIsk Prediction Studies (GRIPS): explanation and elaboration. (2011) (4)
Khoury et al. Respond to “The Epicenter of Translational Science”: Crossing All the T's (2010) (4)
Pre-registration of mathematical models. (2022) (4)
Non-publication and delayed publication of randomized trials on vaccines: a surveyLamberto Manzoli (2014) (4)
IDENTIFICATION OF THRESHOLD FOR LARGE (DRAMATIC) EFFECTS THAT WOULD OBVIATE RANDOMIZED TRIALS IS NOT POSSIBLE. (2022) (4)
Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration (2011) (4)
356 COMMON VARIANTS IN SKELETAL DYSPLASIA GENES ARE ASSOCIATED WITH OSTEOARTHRITIS (2011) (4)
Modern health care as a game theory problem: reply (2015) (4)
Reversals of Established Medical Practices (2016) (4)
P-4-28 Sulpiride and risperidone vs. “classical neuroleptics” in schizophrenia: A follow-up study (1995) (4)
Meta-analyses in environmental and occupational health (2018) (4)
Reply to letter by Ferrante di Ruffano et al.: Patient outcomes in randomized comparisons of diagnostic tests are still the ultimate judge. (2016) (4)
A Genetic Marker Associated with De Quervain’s Tenosynovitis (2017) (4)
Interventions to improve cardiopulmonary resuscitation: a review of meta-analyses and future agenda (2019) (4)
METRADISC-XL: A program for meta-analysis of multidimensional ranked discovery oriented datasets including microarrays (2012) (4)
A Genetic Marker Associated with Shoulder Dislocation (2017) (4)
Correction: Multiple Citation Indicators and Their Composite across Scientific Disciplines (2016) (4)
Robustness of reported postacute health outcomes in children with SARS-CoV-2 infection: a systematic review (2022) (4)
Meta-analyses of hydroxyethyl starch for volume resuscitation. (2013) (4)
Intent to share Annals of Internal Medicine's trial data was not associated with data re-use. (2021) (3)
Conflict of Interest in Nutrition Research-Reply. (2018) (3)
Validation protocols for blood pressure measuring devices (2019) (3)
Estimating conditional vaccine effectiveness (2022) (3)
Using Big Data to Determine Reference Values for Laboratory Tests-Reply. (2018) (3)
Author Reply to: The name of the game: Is preventive screening “cancer screening?” (2019) (3)
Systematic Reviews for Basic Scientists: A Different Beast. (2022) (3)
Meta-research: bird's eye views of primary care research. (2020) (3)
Re-rethinking the article by Thombs and colleagues (2012) (3)
Association of 152 Biomarker Reference Intervals with All-Cause Mortality in Participants of a General United States Survey from 1999 to 2010 (2020) (3)
Comparative evidence on harms in pediatric randomized clinical trials from less developed versus more developed countries is limited. (2018) (3)
Extremely large outlier treatment effects may be a footprint of bias in trials from less developed countries: randomized trials of gabapentinoids. (2019) (3)
Sequential Discovery, Thinking Versus Dredging, and Shrink or Sink (2008) (3)
Erratum: Equivalency of the diagnostic accuracy of the PHQ-8 and PHQ-9: A systematic review and individual participant data meta-analysis (Journal of Physical Chemistry (2019) DOI: 10.1017/S0033291719001314) (2019) (3)
Methods for Evaluating Medical Tests and Biomarkers (2017) (3)
Erratum: STrengthening the reporting of observational studies in epidemiology - Molecular epidemiology (STROBE-ME): An extension of the STROBE statement (Mutagenesis (2012) 27:1 (17-29)) (2012) (3)
Ranking antidepressants (2009) (3)
EMA and FDA psychiatric drug trial guidelines: assessment of guideline development and trial design recommendations (2021) (3)
Correction: Why Most Published Research Findings Are False (2022) (3)
Mother‐to‐child transmission of HIV: developing integration of healthcare programmes with clinical, social and basic research studies Report of the International Workshop held at Chobe Marina Lodge, Kasane, Botswana, 21–25 January 2003 * (2003) (3)
Impact of risk of generalizability biases in adult obesity interventions: A meta‐epidemiological review and meta‐analysis (2021) (3)
Impact of phenotype definition on genome-wide association signals: empirical evaluation in HIV-1 infection (2011) (3)
HELOW: A program for testing extreme homogeneity in meta-analysis (2014) (3)
Preventing tooth loss with biannual dental visits and genetic testing: does it work? (2015) (3)
Guidelines for cardiovascular risk assessment and cholesterol treatment--reply. (2014) (3)
Published articles should not be dead and buried: introducing research updates (2010) (3)
Adherence Interventions to Improve Adherence to Antiretroviral Therapy in Low Income Settings: An Individual Patient Data Network Meta-Analysis (2013) (3)
Authors’ reply to editorial linked to their umbrella review of meta-analyses of observational studies on type 2 diabetes and cancer (2015) (3)
Are all mental disorders related to all other medical diseases and vice versa? (2019) (3)
Comparisons between randomized and non-randomized evidence (2001) (3)
Academic criteria for promotion and tenure in faculties of biomedical sciences: a cross-sectional analysis of 146 universities (2019) (3)
Large Pediatric Randomized Clinical Trials in ClinicalTrials.gov (2021) (3)
An empirical assessment of research practices across 163 clinical trials of tumor-bearing companion dogs (2019) (3)
83 ANALYSIS OF CANDIDATE OSTEOARTHRITIS GENES IN A META-ANALYSIS OF 8 GENOME-WIDE ASSOCIATION STUDIES (2011) (3)
Comparing the vibration of effects due to model, data pre-processing and sampling uncertainty on a large data set in personality psychology (2020) (3)
Scientific petitions and open letters in the era of covid-19 (2020) (3)
Implausible results in human nutrition research Definitive solutions won't come from another million observational papers or small randomized trials (2013) (3)
Reply to Nuijten et al.: Reanalyses actually confirm that US studies overestimate effects in softer research (2014) (3)
Educating educators on research on research (2021) (3)
PROTOCOL: When and how to replicate systematic reviews (2020) (3)
Changes of serum adhesion molecules and cytokines in post-ERCP pancreatitis: adhesion molecules and cytokines in acute pancreatitis. (2014) (3)
Lethal news: The dexterous infiltration of news media by the tobacco industry agenda (2019) (3)
Protein conjugate pneumococcal vaccines (2002) (3)
Why Current Publication May Distort Science (2008) (2)
FDA and EMA clinical research guidelines: Assessment of trial design recommendations for pivotal psychiatric drug trials (Protocol) (2020) (2)
Reporting only relative effect measures was potentially misleading: some good practices for improving the soundness of epidemiological results: Precision in reporting risk ratios. (2021) (2)
Facing up to medical error Milos Jenicek Medical Error a (2011) (2)
HIV: prevention of opportunistic infections. (2005) (2)
Aggressive measures, rising inequalities, and mass formation during the COVID-19 crisis: An overview and proposed way forward (2022) (2)
Estimates of COVID‐19 deaths in Mainland China after abandoning zero COVID policy (2023) (2)
Analysis of fatality impact and seroprevalence surveys in a community sustaining a SARS-CoV-2 superspreading event (2022) (2)
Hypothesis, analysis and synthesis, it's all Greek to me (2019) (2)
Guidelines Do Not Entangle Practitioners With Unavoidable Conflicts as Authors, and When There Is No Evidence, Just Say So. (2018) (2)
NIH funding: The critics respond (2013) (2)
Research and Theories on the Etiology of Mental Diseases: Doomed to Failure? (2015) (2)
Beyond Random Effects: When Small-Study Findings Are More Heterogeneous (2022) (2)
Footprint of publication selection bias on meta-analyses in medicine, environmental sciences, psychology, and economics (2022) (2)
Comprehensive mapping of local and diaspora scientists: a database and analysis of 63951 Greek scientists (2021) (2)
CONSORT Extension for Better Reporting of Harms (2014) (2)
Correction: Large-Scale Evidence for the Effect of the COLIA1 Sp1 Polymorphism on Osteoporosis Outcomes: The GENOMOS Study (2006) (2)
Allocation Concealment in Clinical Trials—Reply (2002) (2)
Achieving balance with power: lessons from the Balanced Anaesthesia Study. (2020) (2)
The Rapid Growth of Mega-Journals: Threats and Opportunities. (2023) (2)
Statistical guidance to authors at top-ranked journals across scientific disciplines (2022) (2)
Reforming Nutritional Epidemiologic Research-Reply. (2019) (2)
Can Lessons Learned from Genome-Wide Research be Applied to Nutrition-Wide and Exposure-Wide Evidence? (2010) (2)
Time-Varying Death Risk After SARS-CoV-2-Infection in Swedish Long-Term Care Facilities (2022) (2)
Using credibility ceilings to explore skepticism about observational evidence. (2020) (2)
Errors (my very own) and the fearful uncertainty of numbers (2014) (2)
Depot aripiprazole: subverted trials and authorisation of a best-selling drug (2021) (2)
Post-publication critique at top-ranked journals across scientific disciplines: a cross-sectional assessment of policies and practice (2022) (2)
Excess death estimates from multiverse analysis in 2009–2021 (2022) (2)
Combining molecular and genetic data from different sources. (2011) (2)
Modeling and research on research. (2014) (2)
The Accuracy of Smartphone Camera Apps to Detect Atrial Fibrillation: A Systematic Review, Meta-Analysis, Meta-Regression and Modeling Study (2019) (2)
Correspondence to Sand et al. “Critical Reappraisal of a Catechol-O-Methyltransferase Transversion Variant in Schizophrenia” (2010) (2)
Discussion on the meeting on ‘Signs and sizes:understanding and replicating statistical findings’ (2019) (2)
Systematic reviews: guidance relevant for studies of older people (2017) (2)
Making Optimal Use of and Extending beyond Polygenic Additive Liability Models (2016) (2)
John Ioannidis: Uncompromising gentle maniac (2015) (2)
Authors' response to V Johnson and Y Yuan (2007) (2)
The Author Responds to “Evaluating p Values and Bayes Factors” (2008) (2)
Treatment options for acute sinusitis in children (2004) (2)
Rethink Funding. (2018) (2)
The effectiveness of long-term psychoanalytical psychotherapy: a meta-analysis. (2010) (2)
Supplementary data tables for "A standardized citation metrics author database annotated for scientific field" (PLoS Biology 2019) (2019) (2)
High-cited favorable studies for COVID-19 treatments ineffective in large trials (2022) (2)
How does exercise treatment compare with antihypertensive medications? A network meta-analysis of 391 RCTs assessing exercise and medication effects on systolic blood pressure (2018) (2)
Expressing Death Risk as Condensed Life Experience and Death Intensity (2013) (2)
Creatine kinase-MB elevation following stent implantation. (2005) (2)
Spin, Bias, and Clinical Utility in Systematic Reviews of Diagnostic Studies. (2020) (2)
Comparative effect sizes in randomised trials from less developed and more developed countries: a meta-epidemiological assessment (2014) (1)
Evidence Relating Health Care Provider Burnout and Quality of Care (2020) (1)
How to use a subgroup analysis : advanced topics in systematic reviews (2014) (1)
Statistical Biases in Science Communication (2017) (1)
Evaluation of Clinical Trial Data Sharing Policy in Leading Medical Journals (2020) (1)
Vitamin D and multiple health outcomes (2016) (1)
Flaws and uncertainties in pandemic global excess death calculations. (2023) (1)
CONSORT Harms 2022 statement, explanation, and elaboration: updated guideline for the reporting of harms in randomised trials (2023) (1)
Infographic. How does exercise treatment compare with antihypertensive medications? (2019) (1)
Transparent Communication of Radiology Research: Reporting Guidelines and Beyond. (2016) (1)
Time-varying risk of death after SARS-CoV-2 infection in Swedish long-term care facility residents: a matched cohort study (2022) (1)
Proceedings of the 4th World Conference on Research Integrity (2016) (1)
Underperforming Big Ideas in Biomedical Research-Reply. (2017) (1)
Declaring competing interests. Types of competing interests would be of interest. (2001) (1)
Off-label prescription: experience is a gloomy lantern that does not even illuminate its bearer. Author response. (2018) (1)
Conflict of Interest and Medical Innovation: Ensuring Integrity While Facilitating Innovation in Medical Research (2014) (1)
COVID-19: A Catalyst for Transforming Randomized Trials (2021) (1)
Neuroprotective efficacy of valproate in stroke: Replacing preclinical replication experiments by flipping coins? (2017) (1)
The Cancer Epidemiology Descriptive Cohort Database: A Tool to Support Population-Based Interdisciplinary Research (2016) (1)
Academic Criteria for Promotion and Tenure Within the Faculty of Medicine: A Cross-Sectional Study of 170 Universities (2018) (1)
Genetics & Genomics and Epigenetics 370 A GENOME-WIDE ASSOCIATION STUDY IDENTIFIES A LOCUS ON CHROMOSOME 7 Q 22 TO INFLUENCE SUSCEPTIBILITY FOR OSTEOARTHRITIS (2009) (1)
Patient Safety Practices Targeted at Diagnostic Errors (NEW) (2013) (1)
103 CIRCULATING microRNAs FOR EARLY DIAGNOSIS OF BOVINE PREGNANCY (2015) (1)
Network meta-analysis of antidepressants – Authors' reply (2018) (1)
Incidence, risk and severity of SARS-CoV-2 reinfections in children and adolescents: a population-level study between March 2020 and July 2022 (2022) (1)
Authors Response to Letters to the editor regarding: ‘Assessing mandatory stay‐ At‐ Home and business closure effects on the spread of COVID‐ 19’ (2021) (1)
Are randomized trials obsolete or more important than ever in the genomic era? (2013) (1)
'Optimal' cutoff selection in studies of depression screening tool accuracy using the PHQ-9, EPDS, or HADS-D: A meta-research study. (2022) (1)
Reply to the Letter to the Editor: “Mixing Apples and Oranges in Assessing Outcomes of Repetitive Transcranial Stimulation Meta-Analyses” (2020) (1)
Conducting umbrella reviews (2022) (1)
Effect Sizes Reported in Highly Cited Emotion Research Compared With Larger Studies and Meta-Analyses Addressing the Same Questions (2021) (1)
An Investigation of Editorial Favoritism in the AER (2012) (1)
In reply II-reversal of medical practices. (2013) (1)
Nail pigmentation and fatigue in a 39-year-old woman. (2003) (1)
Lessons learnt from registration of biomedical research (2023) (1)
A Simulation Study of the Strength of Evidence in the Endorsement of Medications Based on Two Trials with Statistically Significant Results (2017) (1)
Are effect sizes reported in highly cited emotion research overestimated relative to larger studies and meta-analyses addressing the same questions? (2021) (1)
Large Trials vs Meta-analysis of Smaller Trials-Reply (1997) (1)
Hypothesis, analysis and synthesis: it’s all Greek to me! (2019) (1)
Zidovudine in Patients with HIV Infection (1996) (1)
Systematic Review of Medical Evidence (2004) (1)
Pharmacogenetics and association studies in schizophrenia (2003) (1)
Harms reported by patients in rheumatology drug trials: a systematic review of randomized trials in the cochrane library from an OMERACT working group. (2021) (1)
Dissenting Opinions in Nutrition Research-Reply. (2020) (1)
Research accomplishments that are too good to be true: reply to Ting (2014) (1)
Estimating the prevalence of transparency and reproducibility-related research practices in psychology (2014-2017) (2020) (1)
Standardized retrieval of side effects data for meta-analysis: a feasibility study in acute sinusitis (2001) (1)
Abstract MP052: Neither Insulin Secretion nor Genotype Pattern Modify 12-Month Weight Loss Effects of Healthy Low-Fat vs. Healthy Low-Carbohydrate Diets Among Adults with Obesity (2017) (1)
John P. A. Ioannidis (2014) (1)
Effect of intravenous glycoprotein IIb/IIIa receptor antagonists on survival in percutaneous coronary interventions: A meta-analysis (2003) (1)
Data for aggregate statistics in "Hundreds of extreme self-citing scientists revealed in new database" (2019) (1)
Mapping evolving treatment effects for overall and progression-free survival shows patterns across 2109 randomized oncology trials. (2022) (1)
A consensus-based transparency checklist (2019) (1)
Environmental risk factors for non-Hodgkin's lymphoma: umbrella review and comparison of meta-analyses of summary and individual participant data (2022) (1)
Ninth international congress on peer review and scientific publication: call for research (2019) (1)
Hydroxychloroquine and chloroquine for survival in COVID-19: an international collaborative meta-analysis of randomized trials (2020) (1)
External Validation of a Shortened Screening Tool Using Individual Participant Data Meta-Analysis: a Case Study of the Patient Questionnaire-Dep-4. (2021) (1)
Most Healthcare Interventions Tested in Cochrane Reviews are Not Effective According to High Quality Evidence: A Meta-Epidemiological Study (2022) (1)
Validity of reported post-acute health outcomes in children with SARS-CoV-2 infection: a systematic review (2022) (1)
Six principles for assessing scientists for hiring, promotion, and tenure (2018) (1)
Pearls on science, collaboration, and mentorship in health research: A masterclass conversation with Dr. John Ioannidis. (2021) (1)
Early supported discharge : a valuable alternative for some stroke patients (2005) (1)
Author Correction: ‘Stealth’ corporate innovation: an emerging threat for therapeutic drug development (2019) (1)
A Systematic Review of Using Electronic Heath Records to Predict Clinical Events: Assessment of Opportunities and Challenges (2016) (1)
Quality, integrity and utility of COVID-19 science: opportunities for public health researchers (2022) (1)
Heart Rhythm Disorders Autonomic Denervation Added to Pulmonary Vein Isolation for Paroxysmal Atrial Fibrillation (2013) (0)
Session Introduction (2003) (0)
Abstract 16179: Impact of a Genetic Risk Score for Coronary Artery Disease in Reducing Cardiovascular Risk: A Pilot Randomized Controlled Study (2016) (0)
Assessment of systematic effects of methodological characteristics on candidate genetic associations (2012) (0)
Science with or without statistics: Discover-generalize-replicate? Discover-replicate-generalize? (2022) (0)
Influence of pilot and small trials in meta-analyses of behavioral interventions: a meta-epidemiological study (2020) (0)
Statistical guidance to authors at top-ranked scientific journals: A cross-disciplinary assessment (2022) (0)
P Cardiac Imaging iagnostic Performance of Coronary agnetic Resonance Angiography as ompared Against Conventional X-Ray Angiography Meta-Analysis (2016) (0)
Abstract 013: An Environment-wide Association Study Identifies Novel and Replicated Nutrients and Pollutants Associated with Serum Lipid Levels (2012) (0)
Olympus marathon runners metabolism-related genes with performance in Mount Associations of polymorphisms of eight muscle- or (2015) (0)
The Clinical Utility of Prognostic Indices: The Proof of the Pudding Is in the Eating—Reply (2012) (0)
Ninth international congress on peer review and scientific publication—call for abstracts (2021) (0)
Influenza: Vaccination and Treatment (2007) (0)
F OOTPRINT OF P UBLICATION S ELECTION B IAS ON M ETA -A NALYSES IN M EDICINE , E CONOMICS , AND P SYCHOLOGY (2022) (0)
Effect of CCR5-&Dgr;32 Heterozygosity on the Risk of Perinatal HIV-1 Infection: A Meta-Analysis (2003) (0)
Faculty Opinions recommendation of Meta-analyses of observational and genetic association studies of folate intakes or levels and breast cancer risk. (2007) (0)
Mother-to-child transmission of HIV: developing integration of healthcare programmes with clinical, social and basic research studies. Report of the International Workshop held at Chobe Marina Lodge, Kasane, Botswana, 21-25 January 2003. (2003) (0)
Systematic screening for environmental and behavioral determinants identifies factors detrimental to skeletal health (2017) (0)
COVID-19 COVID-19 antibody seroprevalence in Santa Clara County, California (2020) (0)
ASSOCIATION BETWEEN OBESITY AND POSTOPERATIVE ATRIAL FIBRILLATION IN PATIENTS UNDERGOING CARDIAC SURGERY: A SYSTEMATIC REVIEW AND META-ANALYSIS (2013) (0)
Thoracic Electrical Bioimpedance [Internet] (2002) (0)
To Correct or Not to Correct-and How. (2012) (0)
METHODS TO ENHANCE THE REPRODUCIBILITY OF PRECISION MEDICINE. (2016) (0)
In-Depth Analysis of Diagnostic Operating Characteristics Shows that Narrow Band Imaging (NBI) Is an Excellent Test to Differentiate Neoplastic and Hyperplastic Colorectal Polyps: 496 (2012) (0)
Author's Reply (2005) (0)
Are the Results of the Study Valid ? How to Use an Article About Genetic Association : B : Correction (2009) (0)
UvA-DARE ( Digital Academic Repository ) A manifesto for reproducible science (2016) (0)
Correction: Citation impact and social media visibility of Great Barrington and John Snow signatories for COVID-19 strategy (2022) (0)
P045. The MelGene database: A field synopsis of genetic association studies in cutaneous melanoma (2011) (0)
When is Evidence Actionable? Assessing Whether a Program is Ready to Scale (2021) (0)
RESEARCH METHODS & REPORTING (2013) (0)
The genetic basis of cross-phenotype correlation with bone fracture risk: the GEFOS consortium (2013) (0)
Design and quality considerations for randomized controlled trials in systemic sclerosis: a systematic appraisal (2001) (0)
A critical assessment of NICE guidelines for treatment of depression (2023) (0)
Meta-Analysis Evaluation of the Potential Excess of Statistically Significant Findings in Published Genetic Association Studies : Application to Alzheimer ’ s Disease (2008) (0)
Cancer Epidemiology in the 21 st Century Transforming Epidemiology for 21 st Century Medicine and Public Health (2013) (0)
Publishing source code could improve credibility of CEAs (2017) (0)
Korean National Health Insurance Database--Reply. (2016) (0)
Correction to: Industry-funded versus non-profit-funded critical care research: a meta-epidemiological overview (2018) (0)
Contradictions in highly cited clinical research. Author's reply (2005) (0)
Comment on: Neoadjuvant versus adjuvant systemic treatment in breast cancer : A meta-analysis. Authors' reply (2005) (0)
Deep ] neural networks are elaborate regression methods aimed solely at prediction , not estimation or explanation (2019) (0)
Retire Statistical Significance Survey (2019) (0)
Author Correction: A consensus-based transparency checklist (2019) (0)
comment ‘ Stealth ’ corporate innovation : an emerging threat for therapeutic drug development Therapeutic innovations of potentially great clinical impact should embrace the overarching values of research accountability , data transparency and validation through the scientific peer-review process (2019) (0)
Major themes covered by meta-research. (2015) (0)
Retiring statistical significance would give bias a free pass (2019) (0)
1 Title : Redefine Statistical Significance (2017) (0)
Corroborating characteristics of single pivotal trial evidence supporting FDA approval of novel cancer therapies (2020) (0)
Pre-registered protocol (2018) (0)
Potential Reporting Bias in Neuroimaging Studies of Sex Differences (2018) (0)
Data for "Comprehensive mapping of local and diaspora scientists for evaluation, planning and policy purposes: a database and analysis of 63951 Greek scientists" (2021) (0)
STREGA Reporting Recommendations, Extended from STROBE Statement (2009) (0)
FC9 Comprehensive review and field synopsis of genetic associations in cutaneous melanoma (2010) (0)
Systematic identification of interaction effects between genome- and environment-wide associations in type 2 diabetes mellitus (2013) (0)
SWP 2016 / 1 The power of bias in economics research (2015) (0)
Reanalyses of trial results--reply. (2015) (0)
Biomedical Research Findings: Lack of Reproducibility and Approaches for Improvement (2015) (0)
Meta-analyses of Hydroxyethyl Starch (2017) (0)
Additional file 3: Figure S1. of Long noncoding RNAs as novel predictors of survival in human cancer: a systematic review and meta-analysis (2016) (0)
Gender-related variables for health research (2021) (0)
IE DREEM Gr Validation EfH 2010 (2014) (0)
Anticonvulsants for alcohol withdrawal. (meta-analysis) (2005) (0)
Is vitamin C superior to diltiazem for radial artery vasodilation in patients awaiting coronary artery bypass grafting? A randomized double blind study (2002) (0)
Time to abandon early detection cancer screening 1 (2019) (0)
P51 Interaction of epidemic and individual heterogeneity on target populations of clinical trials (1997) (0)
Author and Subject Index (2016) (0)
ZIDOVUDINE IN PATIENTS WITH HIV INFECTION. AUTHORS' REPLY (1996) (0)
23-valent pneumococcal vaccination and HIV [2] (multiple letters) (2000) (0)
Risk of harm in synthetic and biological intervention trials in patients with inflammatory arthritis: protocol for a metaepidemiological study focusing on contextual factors (2021) (0)
HIV-Seropositive Individuals Alveolar Macrophages in Asymptomatic Production by α B Modulates TNF-κ NF - (2000) (0)
Appendix A: Literature Search Strategies (2002) (0)
Value of clinical research: Usefulness tool development and systematic review of 350 randomised controlled trials in preterm birth (2021) (0)
for My Patients ? What Are the Results and Will They Help Me in Caring How to Use an Article About Genetic Association : C : (2009) (0)
compared against conventional x-ray angiography: A meta-analysis Diagnostic performance of coronary magnetic resonance angiography as (2011) (0)
intervals in meta-analysis Plea for routinely presenting prediction (0)
Disclosures Can Always Be Improved-Reply. (2018) (0)
eTable. Characteristics of Subgroup Findings With Partial Corroboration Attempts eFigure. Intravenous Cooling for Nontraumatic Out-of-Hospital Cardiac Arrest for the Outcome of Being Discharged Alive From Hospital (2017) (0)
Performing, communicating and rewarding reproducible research (2016) (0)
The Reproducibility Crisis: Causes and Consequences (2015) (0)
Abstract 2161: Metformin and cancer risk: A cohort study in the UK Clinical Practice Research Datalink analyzed like a randomized trial (2014) (0)
Author's Response Heterogeneity metrics: not perfect, but would not abandon (2010) (0)
Variability in excess deaths across countries with different vulnerability during 2020-2023 (2023) (0)
Opportunistic infections and HIV. (2002) (0)
Association between obesity and postoperative atrial fibrillation in patients undergoing cardiac surgery : a systematic review and meta-analysis Running head : Obesity and postoperative atrial fibrillation (2014) (0)
Testing Clinical Prediction Models-Reply. (2020) (0)
Systematic Identification of Correlates of HIV-1 Infection: An X-Wide Association Study in Zambia (2017) (0)
Availability of evidence and comparative effectiveness for surgical versus drug interventions: an overview of systematic reviews (2023) (0)
Comparison of the accuracy of the 7-item HADS Depression subscale and 14-item total HADS for screening for major depression: A systematic review and individual participant data meta-analysis. (2023) (0)
Federal Funding and Citation Metrics of Biomedical Research in the USA (2022) (0)
Claims of Sex-Gene Interactions—Reply (2007) (0)
023 META-ANALYSIS OF GENOME-WIDE ASSOCIATION STUDIES OF OSTEOARTHRITIS (2009) (0)
Erratum to “Inferior vena cava filters and postoperative outcomes in patients undergoing bariatric surgery: a meta-analysis” ☆: Surgery for Obesity and Related Diseases 10 (2014) 725–733 (2015) (0)
Claims of Sex-Gene Interactions. Authors' reply (2007) (0)
Nonreproducibility of Preclinical Research-Reply. (2017) (0)
Does ECG-gated SPECT provide accurate measurement of left ventricular ejection fraction and volumes? A meta-analysis (2002) (0)
Assessing Predictive Performance Beyond the Framingham Risk Score—Reply (2010) (0)
' s response to reviews Title : A test for reporting bias in trial networks : simulation and case studies (2014) (0)
Error in Figure. (2019) (0)
Syddansk Universitet Intra-and interrater agreement with quantitative positron emission tomography measures using variance component analysis (2017) (0)
EFFECT OF DIET AND INSULIN ON G6PD AND H6PD ACTIVITY OF RAT LIVER (1980) (0)
Title Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder : a systematic review and network meta-analysis (2019) (0)
1001 META-ANALYSES: DATA SHARING (2019) (0)
Study design and the drug development process--reply. (2014) (0)
Neo-adjuvant vs adjuvant treatment— evidence from clinical trials (2006) (0)
Abstract P345: A Diet-Wide Association Study on Blood Pressure- the INTERMAP Study (2012) (0)
Unrestricted weighted least squares represent medical research better than random effects in 67,308 Cochrane meta-analyses. (2023) (0)
Convalescent plasma treatment and mortality in COVID-19 patients: an international collaborative meta-analysis of randomized controlled trials (2020) (0)
Authors’ reply to Foster and colleagues (2015) (0)
There is nothing personal-reply. (2012) (0)
The future of grant proposals is video (2021) (0)
Research authors’ reply to Barlow and Barr and Taylor-Robinson (2016) (0)
Beyond genomics: understanding exposotypes through metabolomics (2018) (0)
Authors’ reply to Pérol and colleagues (2016) (0)
PLOS Science Wednesday: Hi Reddit, we're Dr. John Ioannidis and Dr. Robert Kaplan, and we're here to discuss the importance of improved reporting in scholarly research for Open Access Week (2015) (0)
Solutions to Reduce Unnecessary Imaging-Reply. (2019) (0)
A Multidimensional Prognostic Index in Common Conditions Leading to Death in Older Patients—Reply (2012) (0)
Meta-analysis identi fi es loci affecting levels of the potential osteoarthritis biomarkers sCOMP and uCTX-II with genome wide signi fi cance (2014) (0)
Meta-analyses, multivariate analyses, and coping with the play of chance (1998) (0)
Replantear la financiación (2018) (0)
Considering the methodological limitations and external validity issues of pharmacological drug trials in adult ADHD: An umbrella review (Open Protocol) (2021) (0)
The importance of event rates for clinical site effects in multicenter trials (1998) (0)
IMPACT OF DIASTOLIC DYSFUNCTION ON POST-OPERATIVE OUTCOMES AFTER CARDIAC SURGERY: A META-ANALYSIS (2015) (0)
Response to commentary: Spurious meta-analyses: both critical methodological assessment and statistical correction are needed (2009) (0)
Not-so-surprising findings (2006) (0)
A Genetic Marker Associated with Shoulder Dislocation Authors (2013) (0)
Khoury et al. Reply (2011) (0)
Shaping up science. (2019) (0)
Percutaneous coronary intervention after myocardial infarction and the late open artery hypothesis (2008) (0)
Declaring competing interests (2001) (0)
Usefulness of Medical Conferences—Reply (2012) (0)
OP-IJEJ140141_dyu269 264..282 (2015) (0)
KEYNOTE: HOW TO MAKE MEDICAL RESEARCH BOTH CREDIBLE AND USEFUL (2016) (0)
Authors’ reply to Boucher (2014) (0)
Data for: Redundant meta-analyses are common in genetic epidemiology (2020) (0)
Authors’ reply to Noble and colleagues and Liew and colleagues (2012) (0)
Prevention of Myopia in Children (2017) (0)
TherapeuticsClinical Studies Including Force of the EULAR Standing Committee for systemic lupus erythematosus. Report of a Task EULAR recommendations for the management of (2008) (0)
Nutrition and Health: Setting Realistic Expectations and Changing Research Targets (2021) (0)
Erratum to: Methods for evaluating medical tests and biomarkers (2017) (0)
Patient Health Questionnaire-Depression--4 (2019) (0)
Epicardial foci of atrial arrhythmia apparently originating in the left pulmonary veins (2002) (0)
Faculty Opinions recommendation of Statins, fibrates, and melanoma risk: a systematic review and meta-analysis. (2007) (0)
Immunogenicity and safety of the multicomponent meningococcal B vaccine (4CMenB): a meta-analysis (2017) (0)
Corrigendum to “A genome-wide association study identifies a common variant near the GPR22 gene as a new locus involved in prevalence and progression of osteoarthritis” [Bone. 44S2 (2009) S224] (2010) (0)
Rare loss of function variants in candidate genes and risk of colorectal cancer (2018) (0)
Abstract P094: Genetic Risk, Incident Coronary Heart Disease Events, and the Benefits of a Healthy Lifestyle: Joint and Interacting Effects Across Four US Cohorts (2017) (0)
The Reply. (2016) (0)
Mega-randomized clinical trials for blockbuster drugs--reply. (2013) (0)
Edinburgh Research Explorer Effect of lowdose aspirin on health outcomes (2020) (0)
Phacking in academic research and its implications for statistical inference (0)
Number of meta-research–related publications registered by the Scopus database between January 1 and May 16 2015, by country of corresponding author and by affiliation of any coauthor. (2015) (0)
Pre-registered study protocol (2017) (0)
Interpretation of research results: an indispensable mission impossible? (2008) (0)
Re-use of trial data in the first 10 years of the data-sharing policy of the Annals of Internal Medicine: a survey of published studies (2020) (0)
S13. Symposium: VULNERABILITY FOR SCHIZOPHRENIA: EUROPEAN CLINICAL AND GENETIC HIGH RISK STUDIES (2007) (0)
Why publish single observations? Because Science Matters. (2016) (0)
Homeopathy can offer empirical insights on treatment effects in a null field. (2023) (0)
Letter to the EditorReply from the Authors (2005) (0)
Assessment of Harm (2011) (0)
Epidemiology in the 21 st Century : the Model of Cancer Consortia (2013) (0)
Medical necessity under weak evidence and little or perverse regulatory gatekeeping (2023) (0)
Physical examination. (2018) (0)
Medical screening: prevention can be bad for your health (2012) (0)
Real-world effectiveness of pharmacological treatments in schizophrenia (2007) (0)
Evidence for the Diagnosis and Treatment of Acute Uncomplicated Sinusitis in Children: A Systematic Overview (Technical Report) (2013) (0)
CTLA- 4 gene polymorphisms and autoimmune thyroid diseases: meta-analyses of published and individual-level data (2007) (0)
Authors’ reply to Selvapatt and colleagues, Matthews and colleagues, Badrinath, and Ward and Lee (2015) (0)
Consistency of genome-wide associations across major ancestral groups (2011) (0)
METHODS FOR CALCULATION AND IMPLEMENTATION OF PROPULSION SHAFTING SYSTEM ALIGNMENT (1984) (0)
Reply to Badri et al. on 'Limited benefit of antiretroviral resistance testing in treatment-experienced patients: a meta-analysis'. (2005) (0)
Long noncoding RNAs as novel predictors of survival in human cancer: a systematic review and meta-analysis (2016) (0)
Impact of Phenotype Deﬁnition on Genome-Wide Association Signals: Empirical Evaluation in Human Immunodeﬁciency Virus Type 1 Infection (2011) (0)
Author Correction: A consensus-based transparency checklist (2019) (0)
Non-inferiority versus Superiority for New Antibiotics in an Era of High Antimicrobial Resistance: the case for post-marketing Adaptive Randomized Controlled Trials AUTHORS: *MD (2019) (0)
Urological Survey INFECTION AND INFLAMMATION OF THE GENITOURINARY TRACT (2005) (0)
Implementing clinical trial data sharing requires training a new generation of biomedical researchers (2023) (0)
Is Society caught up in a Death Spiral? Modelling Societal Demise and its Reversal (2023) (0)
Prolific non-research authors in high impact scientific journals: meta-research study (2022) (0)
Extended-Interval Aminoglycosides in Children: More Guidance Is Needed: In Reply (2005) (0)
Published correlational effect sizes in social and developmental psychology (2022) (0)
Examining the readiness of best evidence in medical education guides for integration into educational practice: A meta-synthesis (2018) (0)
Authors' reply (1996) (0)
REVIEW ARTICLES Multivariate models of self-reported health often neglected essential candidate determinants and methodological issues (2005) (0)
An acceptance speech. (2022) (0)
Risk and severity of SARS-CoV-2 reinfections during 2020-2022 in Vojvodina, Serbia: a population-level study (2022) (0)
Reproducibility: Has Cancer Biology Failed beyond Repair? (2022) (0)
Twitter and Mastodon presence of highly-cited scientists (2023) (0)
‘Stealth’ corporate innovation: an emerging threat for therapeutic drug development (2019) (0)
HUMAN GENOME EPIDEMIOLOGY (HuGE) REVIEW CTLA-4 Gene Polymorphisms and Susceptibility to Type 1 Diabetes Mellitus: A HuGE Review and Meta-Analysis (2005) (0)
Evaluating cumulative evidence in genomic epidemiology (2008) (0)
Science, advocacy, and quackery in nutritional books: an analysis of conflicting advice and purported claims of nutritional best-sellers (2020) (0)
Re: Priority setting in research (2017) (0)
Assessing the usefulness of randomized trials in obstetrics and gynaecology. (2023) (0)
How to design preclinical studies in nanomedicine and cell therapy to maximize the prospects of clinical translation (2018) (0)
Mapping the universe of registered reports (2018) (0)
Reproducible pharmacokinetics (2019) (0)
Published Registry-Based Pharmacoepidemiologic Associations Show Limited Concordance with Agnostic Medication-Wide Analyses (2023) (0)
Excess death estimates from multiverse analysis in 2009–2021 (2023) (0)
Federal Funding and Citation Metrics of US Biomedical Researchers, 1996 to 2022 (2022) (0)
The Great Disruption: COVID-19 and the Global Health Crisis (2020) (0)
How do we increase the trustworthiness of medical publications? (2023) (0)
Transparency in infectious disease research: a meta-research survey of specialty journals (2022) (0)
polymorphisms and hematologic and autoimmune diseases receptor gene γ Meta-analysis of the association between low-affinityFc (2013) (0)
Impact of changing the threshold of statistical significance to P lower than 0.005 on recommended medical interventions (2018) (0)
Machine learning augmentation reduces prediction error in collective forecasting: development and validation across prediction markets (2023) (0)
96 Evaluation of predictors and impact of losses to follow-up in the domain of hiv infection (1997) (0)
Contents Vol. 64, 2007 (2007) (0)
An umbrella review of systematic reviews on the impact of the COVID-19 pandemic on cancer prevention and management, and patient needs (2023) (0)
Functional characterization of GWAS loci associated with fracture risk (2013) (0)
Reproducibility in the UK biobank of genome-wide significant signals discovered in earlier genome-wide association studies (2021) (0)
Author Correction: ‘Stealth’ corporate innovation: an emerging threat for therapeutic drug development (2019) (0)
Feasibility indicators in obesity-related behavioral intervention preliminary studies: a historical scoping review (2023) (0)
PREVIOUS SYSTEMATIC REVIEWS (2002) (0)
Individual participant data meta-analysis to compare EPDS accuracy to detect major depression with and without the self-harm item (2023) (0)
Verdi-paper (2018) (0)
Ten (not so) simple rules for clinical trial data-sharing (2023) (0)
Estimates of COVID-19 deaths in Mainland China after abandoning zero COVID policy (2022) (0)
THE arcOGEN CONSORTIUM: STAGE 1 OF A GENOME-WIDE ASSOCIATION SCAN FOR OSTEOARTHRITIS (2010) (0)
Medical advertisements and scientific journals: Time for editors and publishers to take a stance. (2023) (0)
COVID-19 models and expectations – Learning from the pandemic (2022) (0)
"Misfearing" —Culture,Identity,andOurPerceptions ofHealthRisks (2014) (0)
mpact of Schizophrenia Candidate Genes on chizotypy and Cognitive Endophenotypes at the opulation Level (2007) (0)
CONSORT Harms 2022 statement, explanation, and elaboration: updated guideline for the reporting of harms in randomized trials. (2023) (0)
Validation and Confirmation of Associations (2008) (0)
Incidence, Risk, and Severity of SARS-CoV-2 Reinfections in Children and Adolescents Between March 2020 and July 2022 in Serbia (2023) (0)
Implementation of proteomic biomarkers: making it work PERSPECTIVE (2012) (0)
Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance (2015) (0)
Age-stratified infection fatality rate of COVID-19 in the non-elderly informed from pre-vaccination national seroprevalence studies (2022) (0)
Redefine statistical significance (2017) (0)
Corrigendum: Simple, standardized incorporation of genetic risk into non-genetic risk prediction tools for complex traits: coronary heart disease as an example (2015) (0)

This paper list is powered by the following services:

Other Resources About John Ioannidis

en.wikipedia.org
med.stanford.edu

What Schools Are Affiliated With John Ioannidis?

John Ioannidis is affiliated with the following schools:

Tufts University
University of Ioannina
Stanford University
National and Kapodistrian University of Athens
Harvard University